Logitech to Participate in Upcoming Investor Conferences

Logitech to Participate in Upcoming Investor Conferences

LAUSANNE, Switzerland & SAN JOSE, Calif.–(BUSINESS WIRE)–
Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that Company leaders plan to participate at the following investor conferences:

  • Morgan Stanley 25th European Technology, Media & Telecom Conference in Barcelona, Spain on Wednesday, November 12, 2025, 2.00 p.m. CET
  • UBS Global Technology and AI Conference in Scottsdale, Arizona on Tuesday, December 2, 2025, 2.55 p.m. MST

Links to the webcasts will be available on the Logitech corporate website at http://ir.logitech.com.

About Logitech

Logitech designs software-enabled hardware solutions that help businesses thrive and bring people together when working, creating and gaming. As the point of connection between people and the digital world, our mission is to extend human potential in work and play, in a way that is good for people and the planet. Founded in 1981, Logitech International is a Swiss public company listed on the SIX Swiss Exchange (LOGN) and on the Nasdaq Global Select Market (LOGI). Find Logitech and its other brands, including Logitech G, at www.logitech.com or company blog.

Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A. and/or its affiliates in the U.S. and other countries. All other trademarks are the property of their respective owners. For more information about Logitech and its products, visit the company’s website at www.logitech.com.

(LOGIIR)

Editorial Contacts:

Nate Melihercik, Head of Investor Relations – [email protected]

Bruno Rodriguez, Head of Corporate Communications – [email protected]

KEYWORDS: California Spain North America United States Switzerland Europe

INDUSTRY KEYWORDS: Entertainment Consumer Electronics Technology Software Electronic Games Hardware

MEDIA:

Logo
Logo

Bridger Aerospace Achieves Another Record Third Quarter

Recent Federal Wildfire Initiatives and Financing Transaction to Accelerate Growth

BELGRADE, Mont., Nov. 06, 2025 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported record results for the third quarter ended September 30, 2025.

Third Quarter and Recent Highlights:

  • Record third quarter revenue of $67.9 million brings nine-month revenue to $114.3 million
  • Third quarter net income jumps 26% to $34.5 million, adjusted EBITDA increases 4% to $49.1 million compared to the third quarter of 2024
  • Closing of $49 million sale leaseback and $331 million financing package in late October to provide financial flexibility and growth capital for fleet expansion
  • On track to hit the higher end of 2025 Adjusted EBITDA guidance of $42-$48 million
  • Task order extensions that keep a portion of our fleet ready for deployment through October, underscore growing year-round wildfire activity
  • Establishment of the Wildland Fire Service Plan
    and passage of the Fire Ready Nation Act helps the country focus its efforts on preparedness and aggressive wildfire suppression

“2025 has been a defining year for Bridger so far,” shared Sam Davis, Bridger’s Chief Executive Officer. Throughout the year, we have seen more strategic prepositioning and utilization of our aircraft. Statistically, this was a below average fire year; yet our focus on diversifying revenue streams and obtaining long-term contracts has positioned us to outperform. Our strong third quarter results and the completion of our debt refinancing, with the delayed drawn down facility, equips us with the opportunity to acquire new aircraft as we pursue new contracts to serve our customers – whether federal, state, local, or defense. As the threat of wildfire continues to grow, so does our commitment to year-round readiness. This quarter has demonstrated that commitment. For Bridger, financial resilience and a strong balance sheet are not ends in themselves, they are prerequisites for delivering on our mission to protect lives, property, critical infrastructure, and the environment.”

Summary Financial Results

(In thousands)   For the three months ended
September 30,
  For the nine months ended
September 30,
      2025     2024     2025     2024  
Revenues   $ 67,886   $ 64,507   $ 114,283     83,028  
                 
Operating income     39,030     32,865     34,406     12,801  
                 
Net income (loss)     34,519     27,346     19,289   (2,722 )
                 
Adjusted EBITDA     49,075     46,974     54,821     40,237  
                 
Net cash provided by (used in) operating activities             24,761     (2,834 )
                 
Cash and cash equivalents           $ 55,118   $ 33,328  
                 
                 

Third Quarter 2025 Results

Revenue for the third quarter of 2025 was $67.9 million compared to $64.5 million in the third quarter of 2024, an increase of 5%. Excluding $2.1 million of revenue for return to service work performed on the four Spanish Super Scoopers as part of our partnership agreement with MAB Funding, LLC (“MAB”), in the third quarter of 2025, revenue was $65.7 million, up 5% compared to $62.4 million in the third quarter of 2024 after excluding $2.1 million of revenue for return to service work performed under the MAB agreement. The increase in revenue was driven by higher activity with multiple Super Scoopers and surveillance aircraft deployed throughout the third quarter of 2025.

Cost of revenues was $21.1 million in the third quarter of 2025 compared to $23.0 million in the third quarter of 2024.

Selling, general and administrative expenses (“SG&A”) were $7.7 million in the third quarter of 2025 compared to $8.6 million in the third quarter of 2024 reflecting lower non-cash stock-based compensation expense and a decrease in earnout consideration partially offset by an increase in the fair value of our warrants compared to the third quarter of 2024.

Interest expense for the third quarter of 2025 was $5.8 million compared to $6.0 million in the third quarter of 2024.

Net income was $34.5 million in the third quarter of 2025 compared to net income of $27.3 million, in the third quarter of 2024. Earnings per diluted share was $0.37 for the third quarter of 2025 compared to $0.31 per diluted share in the third quarter of 2024. Adjusted EBITDA was $49.1 million in the third quarter of 2025, compared to $47.0 million in the third quarter of 2024.

Definitions and reconciliations of net loss to EBITDA and Adjusted EBITDA, are attached as Exhibit A to this release.

As of September 30, 2025, cash and cash equivalents were $55.1 million compared to $39.3 million as of December 31, 2024. The increase in cash from year end is due to the strong fire season activity.

Year to Date Results

Revenue for the first nine months of 2025 was $114.3 million compared to $83.0 million in the first nine months of 2024, representing an increase of 38%. Excluding $13.1 million of revenue for return to service work performed on the four Spanish Super Scoopers as part of our partnership agreement with MAB in the first nine months of 2025, revenue was $101.1 million compared to $78.0 million in the first nine months of 2024 after excluding $5.0 million for return to service work performed under the MAB agreement. The increase in revenue was driven by significantly higher activity with multiple Super Scoopers and surveillance aircraft deployed earlier in the first nine months of 2025 compared to the first nine months of 2024.

Cost of revenues was $57.0 million in the first nine months of 2025 compared to $42.1 million in the first nine months of 2024. Cost of revenues for the first nine months of 2025 included an increase of $9.6 million of expenses associated with the return-to-service work for the Spanish Super Scoopers compared to the first nine months of 2024.

SG&A expenses were $22.8 million in the first nine months of 2025 compared to $28.2 million for the first nine months of 2024, reflecting lower non-cash stock-based compensation expense and a decrease in fair value of earnout consideration partially offset by an increase in the fair value of our warrants.

Interest expense for the first nine months of 2025 decreased to $17.3 million from $17.8 million in the first nine months of 2024. Bridger also reported Other Income of $1.8 million for the first nine months of 2025 compared to $1.8 million for the first nine months of 2024.

Net income was $19.3 million in the first nine months of 2025 compared to a net loss of $2.7 million in the first nine months of 2024. Adjusted EBITDA was $54.8 million in the first nine months of 2025, compared to $40.2 million in the first nine months of 2024.

Business Outlook

With the continued strong fleet utilization in the third quarter supported by record task orders for our Super Scoopers, we remain on track to end 2025 at the higher end of our previously issued 2025 guidance of Adjusted EBITDA of $42 million to $48 million. Revenue has already exceeded the top end of our guidance range of $105 million to $111 million and is now expected to be between $118 million to $122 million. The Company also expects continued improvement in cash provided by operating activities in 2025.

Definitions and reconciliations of net loss to EBITDA and Adjusted EBITDA, are attached as Exhibit A to this release.

Conference Call

Bridger Aerospace will hold an investor conference call on Thursday, November 6, 2025, at 5:00 p.m. Eastern Time (3:00 p.m. Mountain Time) to discuss these results and its business outlook. Interested parties can access the conference call by dialing 800-343-4136 or 203-518-9843. The conference call will also be broadcast live on the Investor Relations section of our website at https://ir.bridgeraerospace.com. An audio replay will be available through November 13, 2025, by calling 844-512-2921 or 412-317-6671 and using the passcode 11160179. The replay will also be accessible at https://ir.bridgeraerospace.com.

About Bridger Aerospace

Based in Belgrade, Montana, Bridger Aerospace Group Holdings, Inc. is one of the nation’s largest aerial firefighting companies. Bridger provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation, as well as internationally. More information about Bridger Aerospace is available at https://www.bridgeraerospace.com.

Investor Contacts

Alison Ziegler
Darrow Associates
201-220-2678
[email protected]

Forward Looking Statements Certain statements included in this press release that are not historical facts (including any statements concerning plans and objectives of management for future operations of economic performance, or assumptions or forecasts related thereto) are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “predict,” “poised,” “positioned,” “potential,” “seem,” “seek,” “future,” “outlook,” “target,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, 1) the anticipated expansion of Bridger’s operations and increased deployment of Bridger’s aircraft fleet, the anticipated benefits therefrom and the ultimate structure of such acquisitions and/or right to use arrangements; (2) Bridger’s business and growth plans and future financial performance; (3) current and future demand for aerial firefighting services, including the duration or severity of any domestic or international wildfire seasons; (4) the magnitude, timing and benefits from any cost reduction actions; (5) Bridger’s exploration of, need for, or completion of any future financings; (6) Bridger’s potential sources of liquidity and capital resources; (7) Bridger’s remediation plan for its material weaknesses in Bridger’s internal control over financial reporting; and (8) anticipated investments in additional aircraft, capital resources and research and development and the effect of these investments. These statements are based on various assumptions and estimates, whether or not identified in this press release, and on the current expectations of Bridger’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Bridger. These forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to: the ability of Bridger to successfully implement the benefits from the financing transactions; Bridger’s ability to identify and effectively implement any current or future anticipated cost reductions, including any resulting impacts to Bridger’s business and operations therefrom; the duration or severity of any domestic or international wildfire seasons; changes in domestic and foreign business, market, financial, political and legal conditions; Bridger’s failure to realize the anticipated benefits of any acquisitions; Bridger’s successful integration of any aircraft (including achievement of synergies and cost reductions); Bridger’s ability to successfully and timely develop, sell and expand its services, and otherwise implement its growth strategy; risks relating to Bridger’s operations and business, including information technology and cybersecurity risks, loss of requisite licenses, flight safety risks, loss of key customers and deterioration in relationships between Bridger and its employees; risks related to increased competition; risks relating to potential disruption of current plans, operations and infrastructure of Bridger, including as a result of the consummation of any acquisition; risks that Bridger is unable to secure or protect its intellectual property; risks that Bridger experiences difficulties managing its growth and expanding operations; Bridger’s ability to compete with existing or new companies that could cause downward pressure on prices, fewer customer orders, reduced margins, the inability to take advantage of new business opportunities, and the loss of market share; the ability to successfully select, execute or integrate future acquisitions into Bridger’s business, which could result in material adverse effects to operations and financial conditions; and those factors discussed in the sections entitled “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” included in Bridger’s Annual Report filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 14, 2025 for the fiscal year ended December 31, 2024 and in subsequent filings made by Bridger with the SEC from time to time. If any of these risks materialize or Bridger management’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. The risks and uncertainties above are not exhaustive, and there may be additional risks that Bridger presently does not know or that Bridger currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Bridger’s expectations, plans or forecasts of future events and views as of the date of this press release. Bridger anticipates that subsequent events and developments will cause Bridger’s assessments to change. However, while Bridger may elect to update these forward-looking statements at some point in the future, Bridger specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Bridger’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements contained in this press release.

 
BRIDGER AEROSPACE GROUP HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
                 
    For the three months ended
September 30,
  For the nine months ended
September 30,
      2025       2024       2025       2024  
Revenues   $ 67,886     $ 64,507     $ 114,283     $ 83,028  
                 
Cost of revenues:                
Flight operations     12,118       15,122       26,226       25,237  
Maintenance     9,015       7,879       30,814       16,837  
Total cost of revenues     21,133       23,001       57,040       42,074  
Gross profit     46,753       41,506       57,243       40,954  
                 
Selling, general and administrative expense     7,723       8,641       22,837       28,153  
Operating income     39,030       32,865       34,406       12,801  
                 
Interest expense     (5,802 )     (5,989 )     (17,274 )     (17,766 )
Other income     451       470       1,750       1,773  
Income (loss) before income taxes     33,679       27,346       18,882       (3,192 )
Income tax benefit     840             407       470  
Net income (loss)   $ 34,519     $ 27,346     $ 19,289     $ (2,722 )
                 
Series A preferred stock – adjustment to maximum redemptions value     (6,939 )     (6,476 )     (20,136 )     (18,861 )
                 
Earnings (loss) attributable to Common stockholders – basic and diluted   $ 27,580     $ 20,870     $ (847 )   $ (21,583 )
                 
Dilutive adjustments to Earnings (loss) attributable to Common stockholders – basic     6,939       6,476              
                 
Earnings (loss) attributable to Common stockholders – diluted   $ 34,519     $ 27,346     $ (847 )   $ (21,583 )
                 
Earnings (loss) per share – basic   $ 0.50     $ 0.39     $ (0.02 )   $ (0.43 )
Earnings (loss) per share – diluted   $ 0.37     $ 0.31     $ (0.02 )   $ (0.43 )
                 
Weighted average Common stock outstanding – basic     54,637       52,935       54,113       49,633  
Weighted average Common stock outstanding – diluted     92,113       87,956       54,113       49,633  
                 

BRIDGER AEROSPACE GROUP HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
       
  As of
September 30, 2025
  As of
December 31, 2024
ASSETS      
Current assets:      
Cash and cash equivalents $ 55,118     $ 39,336  
Restricted cash   9,257       13,747  
Accounts and note receivable   17,730       5,945  
Aircraft support parts   1,043       857  
Prepaid expenses and other current assets   5,045       3,924  
Total current assets   88,193       63,809  
       
Property, plant and equipment, net   179,701       183,769  
Intangible assets, net   6,000       6,076  
Goodwill   20,888       20,749  
Other noncurrent assets   16,204       16,406  
Total assets $ 310,986     $ 290,809  
       
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT      
Current liabilities:      
Accounts payable $ 6,473     $ 5,330  
Accrued expenses and other current liabilities   11,049       14,057  
Operating right-of-use current liability   2,274       1,835  
Current portion of long-term debt, net of debt issuance costs   2,553       2,170  
Total current liabilities   22,349       23,392  
Long-term accrued expenses and other noncurrent liabilities   4,094       5,388  
Operating right-of-use noncurrent liability   6,225       6,083  
Long-term debt, net of debt issuance costs   200,396       202,469  
Total liabilities $ 233,064     $ 237,332  
       
COMMITMENTS AND CONTINGENCIES      
       
MEZZANINE EQUITY      
Series A preferred stock   400,315       380,179  
       
STOCKHOLDERS’ DEFICIT      
Common stock   6       6  
Additional paid-in capital   86,988       101,495  
Accumulated deficit   (409,950 )     (429,239 )
Accumulated other comprehensive income   563       1,036  
Total stockholders’ deficit   (322,393 )     (326,702 )
Total liabilities, mezzanine equity, and stockholders’ deficit $ 310,986     $ 290,809  
       

BRIDGER AEROSPACE GROUP HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
       
  For the nine months ended September 30,
    2025       2024  
Cash Flows from Operating Activities:      
Net income (loss) $ 19,289     $ (2,722 )
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities, net of acquisition:      
Depreciation and amortization   14,196       14,759  
Stock based compensation expense   4,829       13,719  
Deferred tax benefit         (490 )
Amortization of debt issuance costs   752       692  
(Gain) loss on disposal of fixed assets   (119 )     251  
Change in fair value of the Warrants   1,066       (3,997 )
Change in fair value of earnout consideration   (2,781 )     479  
Realized gain on investments in marketable securities         (16 )
Change in fair value of embedded derivative         (885 )
Changes in operating assets and liabilities:      
Accounts receivable   (11,785 )     (23,453 )
Aircraft support parts   (186 )     (46 )
Prepaid expense and other current and noncurrent assets   2,848       1,303  
Accounts payable, accrued expenses and other liabilities   (3,348 )     (2,428 )
Net cash provided by (used in) operating activities   24,761       (2,834 )
       
Cash Flows from Investing Activities:      
Proceeds from sales of property, plant and equipment   976       505  
Purchases of property, plant and equipment   (10,570 )     (3,099 )
Expenditures for capitalized software   (923 )     (973 )
Collection of note receivable         3,000  
Cash acquired through acquisition         2,592  
Proceeds from sales and maturities of marketable securities         1,055  
Net cash (used in) provided by investing activities   (10,517 )     3,080  
       
Cash Flows from Financing Activities:      
Repayments on debt   (2,442 )     (2,210 )
Restricted stock units settled in cash   (391 )     (694 )
Payment of finance lease liability   (24 )     (20 )
Proceeds from issuance of Common Stock in the registered direct offering         9,169  
Proceeds from issuance of Common Stock in the at-the-market offering         168  
Payment of issuance costs for Common Stock in offerings         (1,006 )
Net cash (used in) provided by financing activities   (2,857 )     5,407  
Effects of exchange rate changes   (95 )      
Net change in cash, cash equivalents and restricted cash   11,292       5,653  
Cash, cash equivalents and restricted cash – beginning of the period   53,083       36,937  
Cash, cash equivalents and restricted cash – end of the period $ 64,375     $ 42,590  
Less: Restricted cash – end of the period   9,257       9,262  
Cash and cash equivalents – end of the period $ 55,118     $ 33,328  

 
EXHIBIT A

Non-GAAP Results and Reconciliations
 

Although Bridger believes that net income or loss, as determined in accordance with GAAP, is the most appropriate earnings measure, we use EBITDA and Adjusted EBITDA as key profitability measures to assess the performance of our business. Bridger believes these measures help illustrate underlying trends in our business and use the measures to establish budgets and operational goals, and communicate internally and externally, in managing our business and evaluating its performance. Bridger also believes these measures help investors compare our operating performance with its results in prior periods in a way that is consistent with how management evaluates such performance.

Each of the profitability measures described below is not recognized under GAAP and does not purport to be an alternative to net income or loss determined in accordance with GAAP as a measure of our performance. Such measures have limitations as analytical tools, and you should not consider any of such measures in isolation or as substitutes for our results as reported under GAAP. EBITDA and Adjusted EBITDA exclude items that can have a significant effect on our profit or loss and should, therefore, be used only in conjunction with our GAAP profit or loss for the period. Bridger’s management compensates for the limitations of using non-GAAP financial measures by using them to supplement GAAP results to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone. Because not all companies use identical calculations, these measures may not be comparable to other similarly titled measures of other companies.

Bridger does not provide a reconciliation of forward-looking measures where Bridger believes such a reconciliation would imply a degree of precision and certainty that could be confusing to investors and is unable to reasonably predict certain items contained in the GAAP measures without unreasonable efforts, such as acquisition costs, integration costs and loss on the disposal or obsolescence of aging aircraft. This is due to the inherent difficulty of forecasting the timing or amount of various items that have not yet occurred and are out of Bridger’s control or cannot be reasonably predicted. For the same reasons, Bridger is unable to address the probable significance of the unavailable information. Forward-looking non-GAAP financial measures provided without the most directly comparable GAAP financial measures may vary materially from the corresponding GAAP financial measures.


EBITDA and Adjusted EBITDA

EBITDA is a non-GAAP profitability measure that represents net income or loss for the period before the impact of the interest expense, income tax expense (benefit) and depreciation and amortization of property, plant and equipment and intangible assets. EBITDA eliminates potential differences in performance caused by variations in capital structures (affecting financing expenses), the cost and age of tangible assets (affecting relative depreciation expense) and the extent to which intangible assets are identifiable (affecting relative amortization expense).

Adjusted EBITDA is a non-GAAP profitability measure that represents EBITDA before certain items that are considered to hinder comparison of the performance of our businesses on a period-over-period basis or with other businesses. During the periods presented, we exclude from Adjusted EBITDA offering costs related to financing and other transactions, which include costs that are required to be expensed in accordance with GAAP. In addition, we exclude from Adjusted EBITDA non-cash stock-based compensation, business development and integration expenses, the change in the fair value of earnout consideration and the change in the fair value of warrants. Our management believes that the inclusion of supplementary adjustments to EBITDA applied in presenting Adjusted EBITDA is appropriate to provide additional information to investors about certain material non-cash items and about unusual items that we do not expect to continue at the same level in the future.

The following table reconciles net income (loss), the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2025, and 2024.

(In thousands) For the three months ended September 30,   For the nine months ended September 30,
    2025       2024       2025       2024  
Net income (loss) $ 34,519     $ 27,346     $ 19,289     $ (2,722 )
Income tax benefit   (840 )           (407 )     (470 )
Depreciation and amortization   8,196       11,471       14,196       14,759  
Interest expense   5,802       5,989       17,274       17,766  
EBITDA   47,677       44,806       50,352       29,333  
Stock-based compensation(1)   1,101       3,369       4,829       13,718  
Business development & integration expenses(2)   331       287       918       748  
Offering costs(3)         105       437       (44 )
Change in fair value of earnout consideration(4)   (34 )     272       (2,781 )     479  
Change in fair value of Warrants(5)         (1,865 )     1,066       (3,997 )
Adjusted EBITDA $ 49,075     $ 46,974     $ 54,821     $ 40,237  

1 Represents non-cash stock-based compensation expense associated with employee and non-employee equity awards.
2 Represents expenses related to integration costs for completed acquisitions and potential acquisition targets and additional business lines.
3 Represents one-time costs for professional service fees related to the preparation for potential offerings that have been expensed during the period.
4 Represents non-cash fair value adjustment for earnout consideration issued in connection with the acquisition of Ignis Technologies, Inc. and Flight Test & Mechanical Solutions, Inc.
5 Represents the non-cash fair value adjustment for the outstanding warrants.



Universal Electronics Reports Financial Results for the Third Quarter 2025

Universal Electronics Reports Financial Results for the Third Quarter 2025

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–
Universal Electronics Inc. (UEI) (Nasdaq: UEIC) reported financial results for the three and nine months ended September 30, 2025.

“Driven by our commitment to advancing control and sensing technologies, we continued to deliver innovative connected products and solutions that enhance user experiences and create value across our customers’ platforms, all while navigating macroeconomic challenges with operational discipline,” said Richard Carnifax, UEI’s COO and Interim CEO. “We are expanding our connected home growth strategy beyond core HVAC OEM offerings, entering adjacent markets such as utilities and multi-dwelling unit property management, while also increasing our presence in the security channel.

“Our top priority remains building sustainable profitability through disciplined cost management and targeted investments in high-return initiatives. As a result, we delivered solid margins and strong cash flow in the third quarter of 2025, further strengthening our balance sheet. While we expect revenue headwinds to continue into the fourth quarter, our focused execution gives us confidence in maintaining profitability next quarter and for the full year — our first full year of profitability since 2022. Confident in our continuing progress and long-term growth strategy, the board of directors authorized the repurchase of the lesser of $3.5 million or approximately 778,000 shares pursuant to our previously announced repurchase program. Looking ahead, our ongoing innovation, expanding product portfolio, and growing partnerships across both existing and complementary markets position UEI to create greater customer value, diversify our revenue base, and drive long-term stockholder return.”

Financial Results for the Three Months Ended September 30: 2025 Compared to 2024

  • GAAP net sales were $90.6 million, compared to $102.1 million.

    • GAAP net sales in connected home were $29.8 million, compared to $26.4 million.
    • GAAP net sales in home entertainment were $60.8 million, compared to $75.7 million.
  • GAAP gross margins were 27.7%, compared to 30.1%; Adjusted non-GAAP gross margins were 29.1%, compared to 30.1%.
  • GAAP operating loss was $4.5 million, compared to GAAP operating income of $0.4 million; Adjusted non-GAAP operating income was $1.6 million, compared to Adjusted non-GAAP operating income of $2.6 million.
  • GAAP net loss was $8.3 million, or $0.62 per share, compared to $2.7 million, or $0.20 per share; Adjusted non-GAAP net income was $1.1 million, or $0.08 per diluted share, compared to Adjusted non-GAAP net income of $1.4 million, or $0.10 per diluted share.
  • Generated operating cash flows of $10.1 million, compared to $5.7 million.
  • At September 30, 2025, cash and cash equivalents were $31.5 million.

Financial Results for the Nine Months Ended September 30: 2025 Compared to 2024

  • GAAP net sales were $280.5 million, compared to $284.4 million.

    • GAAP net sales in connected home were $95.6 million, compared to $73.8 million.
    • GAAP net sales in home entertainment were $184.9 million, compared to $210.6 million.
  • GAAP gross margins were 28.7%, compared to 29.1%; Adjusted non-GAAP gross margins were 29.1%, compared to 29.1%.
  • GAAP operating loss was $7.3 million, compared to $10.9 million; Adjusted non-GAAP operating income was $3.0 million, compared to Adjusted non-GAAP operating loss of $2.0 million.
  • GAAP net loss was $17.5 million, or $1.33 per share, compared to $19.5 million, or $1.51 per share; Adjusted non-GAAP net income was $2.0 million, or $0.15 per diluted share, compared to Adjusted non-GAAP net loss of $3.2 million, or $0.25 per share.
  • Generated operating cash flows of $27.8 million, compared to $8.3 million.

Financial Outlook

For the fourth quarter of 2025, the company expects GAAP net sales to range from $82.0 million to $92.0 million, compared to $110.5 million in the fourth quarter of 2024. GAAP net sales in connected home are expected to range from $26.0 million to $30.0 million, compared to $34.5 million in the fourth quarter of 2024. GAAP net sales in home entertainment are expected to range from $56.0 million to $62.0 million, compared to $76.0 million in the fourth quarter of 2024.

GAAP loss per share for the fourth quarter of 2025 is expected to range from $0.30 to $0.20, compared to GAAP loss per share of $0.35 in the fourth quarter of 2024. Adjusted non-GAAP earnings per diluted share are expected to range from $0.01 to $0.11 per share, compared to Adjusted non-GAAP earnings per diluted share of $0.20 in the fourth quarter of 2024. The fourth quarter 2025 Adjusted non-GAAP earnings per diluted share estimate excludes $0.31 per share related to, among other things, stock-based compensation, amortization of acquired intangible assets, severance, factory restructuring costs, lease termination costs, foreign currency gains and losses and the related tax impact of these adjustments. For a more detailed explanation of non-GAAP measures, please see the Use of non-GAAP Financial Metrics and Additional Financial Information discussion, the Reconciliation of Adjusted non-GAAP Financial Results and Adjusted non-GAAP Financial Outlook and Financial Results, each located elsewhere in this press release.

Conference Call Information

UEI’s management team will hold a conference call today, Thursday, November 6, 2025 at 4:30 p.m. ET / 1:30 p.m. PT, to discuss its third quarter 2025 earnings results, review recent activity and answer questions. To attend the call please register at https://register-conf.media-server.com/register/BI8df83ea44f91406fb46102cbe06c886b to receive a computer-generated dial-in number and a unique pin number. The conference call will also be broadcast live on the investor section of the UEI website where it will be available for replay for 90 days.

Forward-looking Statements

This press release and accompanying schedules contain “forward-looking statements” within the meaning of federal securities laws, including our goals, focus, priorities, strategies and operating model; financial outlook for the fourth quarter of 2025; our expectations about new product introductions and market opportunities; and our expectations regarding revenue headwinds continuing in the fourth quarter. We caution you that these statements are not guarantees of future performance and are subject to numerous risks and uncertainties, including those we identify below and other risk factors that we identify in our annual report on Form 10-K for the year ended December 31, 2024 and the periodic and current reports filed and furnished since then.

Risks that could affect forward-looking statements in this press release include: our continued ability to timely develop and deliver innovative control solutions and technologies that are accepted by our customers, both near- and long-term; our ability to attract new customers and to successfully capture new sales in all markets we serve, including new product and customer wins in the connected home markets as anticipated by management; our ability to continue optimizing our manufacturing footprint and realize the lower concentration risks as expected by management; our ability to maintain our market share in the traditional subscription broadcast market; our ability to manage through the worldwide inflationary pressures and macroeconomic conditions, including the continued strength of the U.S. Dollar as compared to the functional currencies in countries where we conduct our operations; our ability to continue to manage our business, inventories and cash flows to achieve our net sales, margins and earnings through financial discipline, operational efficiency, product line management, liquidity requirements, capital expenditures and other investment spending expectations; our continued ability to successfully enforce our patented technology, including with respect to our litigation against Roku; our continued ability to strategically enhance, expand, and monetize our intellectual property portfolios; the continued fluctuation in our market capitalization and the effects our currently announced stock repurchase program may have; the use of artificial intelligence applications which could result in cybersecurity incidents that implicate the personal data of end users or other unintended ethical, reputational, competitive harm or legal liability; our ability to mitigate the effects that tariffs could have on our profitability through price increases and other efforts; the direct and indirect impact we may experience with respect to our business and financial results and management’s ability to anticipate and mitigate the impact stemming from the continued economic uncertainty affecting consumers’ confidence and spending, natural disasters or other events beyond our control, public health crises (including an outbreak of infectious disease), governmental actions, including the changes in or enhanced use of laws, regulations and policies may have on our business including the impact of decreased governmental incentive programs worldwide or of enhanced or expanded trade regulations, including the expanded use of domestic and retaliatory tariffs, the effects of political unrest, war, terrorist activities, or other hostilities; the effects and uncertainties and other factors more fully described in our reports filed with the Securities and Exchange Commission. Since it is not possible to predict or identify all of the risks, uncertainties and other factors that may affect future results, the above list should not be considered a complete list. Further, any of these factors could cause actual results to differ materially from the expectations we express or imply in this press release. We make these forward-looking statements as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Use of Non-GAAP Financial Metrics and Additional Financial Information

In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, UEI provides Adjusted non-GAAP information as additional information for its operating results. References to Adjusted non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. UEI’s management uses these measures for reviewing the financial results of UEI for budget planning purposes and for making operational and financial decisions. Management believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate UEI’s core operating and financial performance and business trends consistent with how management evaluates such performance and trends. Additionally, management believes these measures facilitate comparisons with the core operating and financial results and business trends of competitors and other companies.

Adjusted non-GAAP gross profit is defined as gross profit excluding impairment and stock-based compensation expenses. Adjusted non-GAAP operating expenses are defined as operating expenses excluding stock-based compensation expense, amortization of acquired intangibles assets, severance, factory restructuring costs, lease abandonment costs and costs associated with certain litigation efforts. Adjusted non-GAAP net income (loss) is defined as net loss excluding the aforementioned items, foreign currency gains and losses, as well as the related tax effects of all adjustments. Adjusted non-GAAP income (loss) per diluted share is calculated using Adjusted non-GAAP net income (loss). A reconciliation of these financial measures to the most directly comparable GAAP financial measures is included at the end of this press release.

About Universal Electronics

Universal Electronics Inc. (Nasdaq: UEIC) is the global leader in wireless universal control solutions for the home. The company brings to life millions of innovative control products each year that focus on a user-centric approach to building control products and applications that simplify user interaction with highly complex technologies in the home, removing interoperability challenges as a roadblock for user adoption, with privacy first and a secure by design approach to today’s smart devices. Our solutions are trusted by the world’s leading brands in home entertainment and the connected home markets, including Fortune 500 customers Daikin, Carrier, Comcast, Vivint Smart Home, Samsung, Sony, Hunter Douglas and Somfy. The company’s pioneering breakthrough innovations include its award-winning voice control entertainment remote controls and QuickSet Cloud, the world’s leading platform for automated device and service discovery, set-up and control, and user experience personalization for the home. For more information, visit www.uei.com.

UNIVERSAL ELECTRONICS INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share-related data)

(Unaudited)

 

 

 

September 30, 2025

 

December 31, 2024

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

31,506

 

 

$

26,783

 

Accounts receivable, net

 

 

83,800

 

 

 

114,182

 

Contract assets

 

 

5,739

 

 

 

10,346

 

Inventories

 

 

80,605

 

 

 

79,355

 

Prepaid expenses and other current assets

 

 

6,081

 

 

 

9,478

 

Income tax receivable

 

 

849

 

 

 

2,350

 

Total current assets

 

 

208,580

 

 

 

242,494

 

Property, plant and equipment, net

 

 

29,331

 

 

 

34,207

 

Intangible assets, net

 

 

22,583

 

 

 

24,038

 

Operating lease right-of-use assets

 

 

11,003

 

 

 

14,322

 

Deferred income taxes

 

 

5,937

 

 

 

6,425

 

Other assets

 

 

3,263

 

 

 

1,868

 

Total assets

 

$

280,697

 

 

$

323,354

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

59,200

 

 

$

72,031

 

Lines of credit

 

 

18,256

 

 

 

36,960

 

Accrued compensation

 

 

19,136

 

 

 

20,927

 

Accrued sales discounts, rebates and royalties

 

 

5,234

 

 

 

5,204

 

Accrued income taxes

 

 

4,025

 

 

 

2,161

 

Other accrued liabilities

 

 

18,867

 

 

 

21,008

 

Total current liabilities

 

 

124,718

 

 

 

158,291

 

Long-term liabilities:

 

 

 

 

Operating lease obligations

 

 

6,889

 

 

 

9,232

 

Deferred income taxes

 

 

2,144

 

 

 

1,931

 

Income tax payable

 

 

72

 

 

 

72

 

Other long-term liabilities

 

 

729

 

 

 

723

 

Total liabilities

 

 

134,552

 

 

 

170,249

 

Commitments and contingencies

 

 

 

 

Stockholders’ equity:

 

 

 

 

Preferred stock, $0.01 par value, 5,000,000 shares authorized; none issued or outstanding

 

 

 

 

 

 

Common stock, $0.01 par value, 50,000,000 shares authorized; 26,137,645 and 25,712,940 shares issued on September 30, 2025 and December 31, 2024, respectively

 

 

261

 

 

 

257

 

Paid-in capital

 

 

349,399

 

 

 

344,697

 

Treasury stock, at cost, 12,772,743 and 12,666,443 shares on September 30, 2025 and December 31, 2024, respectively

 

 

(372,710

)

 

 

(371,930

)

Accumulated other comprehensive income (loss)

 

 

(21,721

)

 

 

(28,350

)

Retained earnings

 

 

190,916

 

 

 

208,431

 

Total stockholders’ equity

 

 

146,145

 

 

 

153,105

 

Total liabilities and stockholders’ equity

 

$

280,697

 

 

$

323,354

 

UNIVERSAL ELECTRONICS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Net sales

$

90,552

 

 

$

102,073

 

 

$

280,543

 

 

$

284,425

 

Cost of sales

 

65,430

 

 

 

71,341

 

 

 

200,142

 

 

 

201,753

 

Gross profit

 

25,122

 

 

 

30,732

 

 

 

80,401

 

 

 

82,672

 

Research and development expenses

 

6,687

 

 

 

7,338

 

 

 

20,877

 

 

 

22,679

 

Selling, general and administrative expenses

 

22,106

 

 

 

22,872

 

 

 

65,941

 

 

 

68,213

 

Factory restructuring charges

 

841

 

 

 

104

 

 

 

841

 

 

 

2,723

 

Operating income (loss)

 

(4,512

)

 

 

418

 

 

 

(7,258

)

 

 

(10,943

)

Interest income (expense), net

 

(244

)

 

 

(891

)

 

 

(955

)

 

 

(2,656

)

Other income (expense), net

 

(1,002

)

 

 

274

 

 

 

(2,701

)

 

 

105

 

Income (loss) before provision for income taxes

 

(5,758

)

 

 

(199

)

 

 

(10,914

)

 

 

(13,494

)

Provision for income taxes

 

2,571

 

 

 

2,459

 

 

 

6,601

 

 

 

6,006

 

Net income (loss)

$

(8,329

)

 

$

(2,658

)

 

$

(17,515

)

 

$

(19,500

)

 

 

 

 

 

 

 

 

Earnings (loss) per share:

 

 

 

 

 

 

Basic

$

(0.62

)

 

$

(0.20

)

 

$

(1.33

)

 

$

(1.51

)

Diluted

$

(0.62

)

 

$

(0.20

)

 

$

(1.33

)

 

$

(1.51

)

Shares used in computing earnings (loss) per share:

 

 

 

 

 

 

 

Basic

 

13,340

 

 

 

12,985

 

 

 

13,207

 

 

 

12,935

 

Diluted

 

13,340

 

 

 

12,985

 

 

 

13,207

 

 

 

12,935

 

UNIVERSAL ELECTRONICS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

 

2024

 

Cash flows from operating activities:

 

 

 

 

Net income (loss)

 

$

(17,515

)

 

$

(19,500

)

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:

 

 

 

 

Depreciation and amortization

 

 

11,080

 

 

 

13,528

 

Provision for credit losses

 

 

161

 

 

 

17

 

Deferred income taxes

 

 

961

 

 

 

1,056

 

Shares issued for employee benefit plan

 

 

431

 

 

 

940

 

Employee and director stock-based compensation

 

 

4,274

 

 

 

5,015

 

Impairment of long-lived assets

 

 

1,291

 

 

 

148

 

Changes in operating assets and liabilities:

 

 

 

 

Accounts receivable and contract assets

 

 

38,895

 

 

 

5,367

 

Inventories

 

 

1,403

 

 

 

(453

)

Prepaid expenses and other assets

 

 

5,666

 

 

 

826

 

Accounts payable and accrued liabilities

 

 

(22,166

)

 

 

(102

)

Accrued income taxes

 

 

3,356

 

 

 

1,497

 

Net cash provided by (used for) operating activities

 

 

27,837

 

 

 

8,339

 

Cash flows from investing activities:

 

 

 

 

Purchase of Blue Chip Swap securities

 

 

(2,544

)

 

 

 

Sale of Blue Chip Swap securities

 

 

2,314

 

 

 

 

Acquisitions of property, plant and equipment

 

 

(3,143

)

 

 

(3,541

)

Acquisitions of intangible assets

 

 

(2,331

)

 

 

(3,150

)

Net cash provided by (used for) investing activities

 

 

(5,704

)

 

 

(6,691

)

Cash flows from financing activities:

 

 

 

 

Borrowings under lines of credit

 

 

70,660

 

 

 

57,794

 

Repayments on lines of credit

 

 

(89,714

)

 

 

(73,000

)

Treasury stock purchased

 

 

(780

)

 

 

(1,896

)

Net cash provided by (used for) financing activities

 

 

(19,834

)

 

 

(17,102

)

Effect of foreign currency exchange rates on cash and cash equivalents

 

 

2,424

 

 

 

(1,010

)

Net increase (decrease) in cash and cash equivalents

 

 

4,723

 

 

 

(16,464

)

Cash and cash equivalents at beginning of period

 

 

26,783

 

 

 

42,751

 

Cash and cash equivalents at end of period

 

$

31,506

 

 

$

26,287

 

 

 

 

 

 

Supplemental cash flow information:

 

 

 

 

Income taxes paid

 

$

2,673

 

 

$

2,922

 

Interest paid

 

$

1,708

 

 

$

3,900

 

UNIVERSAL ELECTRONICS INC.

NET SALES BY CHANNEL

(In thousands)

(Unaudited)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

(In thousands)

 

2025

 

 

2024

 

 

2025

 

 

2024

Connected home (1)

$

29,793

 

$

26,368

 

$

95,621

 

$

73,830

Home entertainment (2)

 

60,759

 

 

75,705

 

 

184,922

 

 

210,595

Net sales

$

90,552

 

$

102,073

 

$

280,543

 

$

284,425

(1)

The connected home channel represents climate control, smart home and security product sales sold primarily to HVAC, security, home automation and home appliance customers.

(2)

The home entertainment channel represents entertainment-related product sales sold primarily to video service providers, consumer electronics original equipment manufacturers (“OEMs”) and retailers. It also includes sales associated with intellectual property licensing and our cloud-based software solution.

UNIVERSAL ELECTRONICS INC.

RECONCILIATION OF ADJUSTED NON-GAAP FINANCIAL RESULTS

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Cost of sales:

 

 

 

 

 

 

 

 

Cost of sales – GAAP

 

$

65,430

 

 

$

71,341

 

 

$

200,142

 

 

$

201,753

 

Impairment of long-lived assets (1)

 

 

(1,187

)

 

 

 

 

 

(1,187

)

 

 

 

Stock-based compensation expense

 

 

(13

)

 

 

(25

)

 

 

(41

)

 

 

(72

)

Adjusted non-GAAP cost of sales

 

 

64,230

 

 

 

71,316

 

 

 

198,914

 

 

 

201,681

 

Adjusted non-GAAP gross profit

 

$

26,322

 

 

$

30,757

 

 

$

81,629

 

 

$

82,744

 

 

 

 

 

 

 

 

 

 

Gross margin:

 

 

 

 

 

 

 

 

Gross margin – GAAP

 

 

27.7

%

 

 

30.1

%

 

 

28.7

%

 

 

29.1

%

Impairment of long-lived assets (1)

 

 

1.4

%

 

 

%

 

 

0.4

%

 

 

%

Stock-based compensation expense

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Adjusted non-GAAP gross margin

 

 

29.1

%

 

 

30.1

%

 

 

29.1

%

 

 

29.1

%

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Operating expenses – GAAP

 

$

29,634

 

 

$

30,314

 

 

$

87,659

 

 

$

93,615

 

Stock-based compensation expense

 

 

(828

)

 

 

(1,626

)

 

 

(4,233

)

 

 

(4,944

)

Amortization of acquired intangible assets

 

 

(206

)

 

 

(219

)

 

 

(632

)

 

 

(686

)

Severance (2)

 

 

(1,705

)

 

 

 

 

 

(1,980

)

 

 

 

Factory restructuring charges (3)

 

 

(841

)

 

 

(104

)

 

 

(841

)

 

 

(2,722

)

Lease abandonment (4)

 

 

(1,302

)

 

 

 

 

 

(1,302

)

 

 

 

Litigation costs (5)

 

 

 

 

 

(175

)

 

 

 

 

 

(532

)

Adjusted non-GAAP operating expenses

 

$

24,752

 

 

$

28,190

 

 

$

78,671

 

 

$

84,731

 

 

 

 

 

 

 

 

 

 

Operating income (loss):

 

 

 

 

 

 

 

 

Operating income (loss) – GAAP

 

$

(4,512

)

 

$

418

 

 

$

(7,258

)

 

$

(10,943

)

Impairment of long-lived assets (1)

 

 

1,187

 

 

 

 

 

 

1,187

 

 

 

 

Stock-based compensation expense

 

 

841

 

 

 

1,651

 

 

 

4,274

 

 

 

5,016

 

Amortization of acquired intangible assets

 

 

206

 

 

 

219

 

 

 

632

 

 

 

686

 

Severance (2)

 

 

1,705

 

 

 

 

 

 

1,980

 

 

 

 

Factory restructuring costs (3)

 

 

841

 

 

 

104

 

 

 

841

 

 

 

2,722

 

Lease abandonment (4)

 

 

1,302

 

 

 

 

 

 

1,302

 

 

 

 

Litigation costs (5)

 

 

 

 

 

175

 

 

 

 

 

 

532

 

Adjusted non-GAAP operating income (loss)

 

$

1,570

 

 

$

2,567

 

 

$

2,958

 

 

$

(1,987

)

 

 

 

 

 

 

 

 

 

Adjusted pro forma operating income (loss) as a percentage of net sales

 

 

1.7

%

 

 

2.5

%

 

 

1.1

%

 

 

(0.7

)%

UNIVERSAL ELECTRONICS INC.

RECONCILIATION OF ADJUSTED NON-GAAP FINANCIAL RESULTS

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Net income (loss):

 

 

 

 

 

 

 

 

Net income (loss) – GAAP

 

$

(8,329

)

 

$

(2,658

)

 

$

(17,515

)

 

$

(19,500

)

Impairment of long-lived assets (1)

 

 

1,187

 

 

 

 

 

 

1,187

 

 

 

 

Stock-based compensation expense

 

 

841

 

 

 

1,651

 

 

 

4,274

 

 

 

5,016

 

Amortization of acquired intangible assets

 

 

206

 

 

 

219

 

 

 

632

 

 

 

686

 

Severance (2)

 

 

1,705

 

 

 

 

 

 

1,980

 

 

 

 

Factory restructuring costs (3)

 

 

841

 

 

 

104

 

 

 

841

 

 

 

2,722

 

Lease abandonment (4)

 

 

1,302

 

 

 

 

 

 

1,302

 

 

 

 

Litigation costs (5)

 

 

 

 

 

175

 

 

 

 

 

 

532

 

Foreign currency (gain)/loss

 

 

1,109

 

 

 

(264

)

 

 

2,651

 

 

 

194

 

Income tax provision on adjustments

 

 

2,248

 

 

 

2,134

 

 

 

6,605

 

 

 

7,101

 

Adjusted non-GAAP net income (loss)

 

$

1,110

 

 

$

1,361

 

 

$

1,957

 

 

$

(3,249

)

 

 

 

 

 

 

 

 

 

Diluted shares used in computing earnings (loss) per share:

 

 

 

 

 

 

 

 

GAAP

 

 

13,340

 

 

 

12,985

 

 

 

13,207

 

 

 

12,935

 

Adjusted non-GAAP

 

 

13,569

 

 

 

13,140

 

 

 

13,488

 

 

 

12,935

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share – GAAP

 

$

(0.62

)

 

$

(0.20

)

 

$

(1.33

)

 

$

(1.51

)

Total adjustments

 

$

0.70

 

 

$

0.31

 

 

$

1.44

 

 

$

1.26

 

Adjusted non-GAAP diluted earnings (loss) per share

 

$

0.08

 

 

$

0.10

 

 

$

0.15

 

 

$

(0.25

)

(1)

The three and nine months ended September 30, 2025 include impairment charges relating to machinery and equipment and leasehold improvements associated with the shut down of our Mexico manufacturing facility. The shut down is expected to be completed by the end of 2025.

 

 

(2)

The three months and nine months ended September 30, 2025 include severance costs associated with a global reduction in force primarily impacting roles within the engineering and research and development functions. Additionally, the nine months ended September 30, 2025 include severance per the Transition Agreement and Release of Claims dated March 19, 2025 between Paul D. Arling and the company.

 

 

(3)

The three and nine months ended September 30, 2025 include severance and other exit costs associated with the closure of our Mexico manufacturing facility. The three and nine months ended September 30, 2024 include severance and other exit costs associated with the closure of our southwestern China factory and the streamlining of our Mexico manufacturing facility.

 

 

(4)

The three and nine months ended September 30, 2025 include costs resulting from the abandonment of our office space in Carlsbad, California.

 

 

(5)

The three and nine months ended September 30, 2024 include expenses related to our various litigation matters involving Roku, Inc. and certain other related entities including three Federal District Court cases, two International Trade Commission investigations and the defense of various inter partes reviews and appeals before the US Patent and Trademark Board.

UNIVERSAL ELECTRONICS INC.

RECONCILIATION OF ADJUSTED NON-GAAP FINANCIAL OUTLOOK AND FINANCIAL RESULTS

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended December 31,

 

 

2025

 

 

 

2024

 

 

 

Low Range

 

High Range

 

Actual

Net sales:

 

 

 

 

 

 

Connected home

 

$

26,000

 

 

$

30,000

 

 

$

34,428

 

Home entertainment

 

 

56,000

 

 

 

62,000

 

 

 

76,026

 

Net sales – GAAP

 

$

82,000

 

 

$

92,000

 

 

$

110,454

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

Diluted earnings (loss) per share – GAAP

 

$

(0.30

)

 

$

(0.20

)

 

$

(0.35

)

Total adjustments (1)

 

$

0.31

 

 

$

0.31

 

 

$

0.54

 

Adjusted non-GAAP diluted earnings (loss) per share

 

$

0.01

 

 

$

0.11

 

 

$

0.20

 

(1)

Includes adjustments for stock-based compensation expense, amortization of acquired intangibles assets, severance, factory restructuring costs, lease termination costs, foreign currency gains and losses and the related tax impact of these adjustments. The three months ended December 31, 2024 also includes adjustments for costs associated with certain litigation efforts and a legal judgment.

 

UEI: Sui Man Ho, Interim CFO, UEI, [email protected] 480-530-3000

Investors: Richard Land, Alliance Advisors, [email protected], 212-838-3777

KEYWORDS: Arizona United States North America

INDUSTRY KEYWORDS: Electronic Design Automation Consumer Electronics Security Technology Audio/Video Software Hardware

MEDIA:

Logo
Logo

TruBridge Announces Third Quarter 2025 Results

TruBridge Announces Third Quarter 2025 Results

MOBILE, Ala.–(BUSINESS WIRE)–
TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced financial results for the third quarter and nine months ended September 30, 2025.

Third Quarter 2025 Highlights

All comparisons are to the quarter ended September 30, 2024, unless otherwise noted

  • Total bookings of $15.5 million compared to $21.0 million
  • Total revenue of $86.1 million compared to $84.7 million

    • Recurring revenue represented 94% of total revenue
  • Financial Health revenue of $54.5 million compared to $54.7 million

    • Financial Health revenue represented 63% of TruBridge’s total revenue
  • GAAP net income of $5.6 million compared to a net loss of $9.1 million
  • Non-GAAP net income of $12.8 million compared to a net loss of $3.1 million
  • Adjusted EBITDA of $16.3 million compared to $14.7 million

Commenting on the results, Chris Fowler, chief executive officer at TruBridge, Inc., stated, “In the third quarter, we delivered solid revenue and achieved a 19% Adjusted EBITDA margin, further expanding profitability in a sustainable way that will allow for continued improvement over time. We’ve made significant progress over the past two years enhancing the financial performance of our business, meaningfully expanding margins, generating free cash flow, and de-levering the balance sheet.”

“Now that we successfully built a solid foundation and have proven our ability to execute on our financial objectives, we are applying the same disciplined approach to improving our performance across the business,” added Fowler. “As such, we continue to make leadership enhancements to ensure we have the most effective people on board. Most recently we hired a Chief Business Officer to oversee client-centered excellence, sales and marketing to drive growth. We have continued to bring in the right leadership, including the head of India operations to lead the restart of our offshore transition process. Together, these improvements will optimize our performance over time allowing us to achieve our strategic business objectives and deliver even greater EBITDA margins and free cash flow in the years to come.”

Financial Guidance

For the fourth quarter of 2025, TruBridge expects to generate:

  • Total revenue of $86 million to $89 million
  • Adjusted EBITDA of $16.5 million to $19.5 million

For the full year 2025, TruBridge expects to generate:

  • Total revenue of $345 million to $348 million; revised from $345 million to $350 million
  • Adjusted EBITDA of $65 million to $68 million; revised from $62 million to $67 million

Conference Call

TruBridge will hold a conference call and live webcast to discuss third quarter 2025 results on Friday, November 7, 2025, at 7:30 a.m. Central time/8:30 a.m. Eastern time. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A 30-day online replay will be available approximately one hour following the conclusion of the live webcast. To listen to the live webcast or access the replay, visit the Company’s investor relations website, investors.trubridge.com.

About TruBridge

TruBridge proudly supports rural and community healthcare providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, we offer a mix of technology, services, and strategic expertise — including revenue cycle management (RCM), electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, deeply personal care close to home.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as “expects,” “anticipates,” “estimates,” “believes,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the Company’s future financial and operational results are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: saturation of our target market and hospital consolidations; unfavorable economic or market conditions that may cause a decline in spending for information technology and services; significant legislative and regulatory uncertainty in the healthcare industry; exposure to liability for failure to comply with regulatory requirements; transition to a subscription based recurring revenue model and modernization of our technology; competition with companies that have greater financial, technical and marketing resources than we have; potential future acquisitions that may be expensive, time consuming, and subject to other inherent risks; our ability to attract and retain qualified personnel in a global workforce; disruption from periodic restructuring of our sales force; slower than anticipated development of the market for Financial Health services; potential inability to properly manage growth in new markets we may enter; potential failure to effectively implement a new enterprise resource planning software solution; exposure to numerous and often conflicting laws, regulations, policies, standards or other requirements through our domestic and international business activities; potential litigation against us and investigations; our use of offshore third-party resources; competitive and litigation risk related to the use of artificial intelligence; potential failure to develop new products or enhance current products that keep pace with market demands; failure of our products to provide accurate and timely information for clinical decision-making; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases free of undetected errors or problems; failure to convince customers to migrate to current or future releases of our products; failure to maintain our margins and service rates; increase in the percentage of total revenues represented by service revenues, which have lower gross margins; exposure to liability in the event we provide inaccurate claims data to payors; exposure to liability claims arising out of the licensing of our software and provision of services; dependence on licenses of rights, products and services from third parties; failure to protect our intellectual property rights; exposure to significant license fees or damages for intellectual property infringement; interruptions in our power supply and/or telecommunications capabilities; potential inability to secure additional financing on favorable terms to meet our future capital needs; our substantial indebtedness, and our ability to incur additional indebtedness in the future; pressures on cash flow to service our outstanding debt; restrictive terms of our credit agreement on our current and future operations; changes in and interpretations of financial accounting matters that govern the measurement of our performance; significant charges to earnings if our goodwill or intangible assets become impaired; fluctuations in quarterly financial performance due to various factors; volatility in our stock price; failure to maintain effective internal control over financial reporting; inherent limitations in our internal control over financial reporting; vulnerability to significant damage from natural disasters; market risks related to interest rate changes; potential material adverse effects due to macroeconomic conditions; we do not anticipate paying dividends on our common stock; actions of activist stockholders against us; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.

TruBridge, Inc.
Condensed Consolidated Statements of Operations
(In ‘000s, except per share data)
(Unaudited)

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

2025

 

2024 *

 

2025

 

2024 *

Revenues
Financial Health

$

54,501

 

$

54,672

 

$

164,918

 

$

162,620

 

Patient Care

 

31,605

 

 

30,028

 

 

94,125

 

 

91,796

 

Total revenues

 

86,106

 

 

84,700

 

 

259,043

 

 

254,416

 

 
Expenses
Costs of revenue (exclusive of amortization and depreciation)
Financial Health

 

29,335

 

 

29,185

 

 

85,835

 

 

89,051

 

Patient Care

 

12,713

 

 

13,184

 

 

36,996

 

 

38,421

 

Total costs of revenue (exclusive of amortization and depreciation)

 

42,048

 

 

42,369

 

 

122,831

 

 

127,472

 

Product development

 

8,171

 

 

7,735

 

 

24,530

 

 

26,629

 

Sales and marketing

 

5,673

 

 

5,944

 

 

19,123

 

 

20,351

 

General and administrative

 

19,416

 

 

19,376

 

 

56,957

 

 

57,651

 

Amortization

 

6,487

 

 

6,183

 

 

18,901

 

 

21,158

 

Depreciation

 

243

 

 

279

 

 

846

 

 

1,079

 

Total expenses

 

82,038

 

 

81,886

 

 

243,188

 

 

254,340

 

 
Operating income

 

4,068

 

 

2,814

 

 

15,855

 

 

76

 

 
Other (expense) income :
Interest expense

 

(3,003

)

 

(4,033

)

 

(9,450

)

 

(12,348

)

Other income (expense)

 

287

 

 

(376

)

 

566

 

 

1,139

 

Total other expense

 

(2,716

)

 

(4,409

)

 

(8,884

)

 

(11,209

)

 
Income (loss) before taxes

 

1,352

 

 

(1,595

)

 

6,971

 

 

(11,133

)

 
(Benefit from) provision for income taxes

 

(4,250

)

 

7,553

 

 

(1,670

)

 

4,257

 

 
Net income (loss)

$

5,602

 

$

(9,148

)

$

8,641

 

$

(15,390

)

 
Net income (loss) per common share—basic

$

0.37

 

$

(0.61

)

$

0.58

 

$

(1.04

)

Net income (loss) per common share—diluted

$

0.37

 

$

(0.61

)

$

0.58

 

$

(1.04

)

 
Weighted average shares outstanding used in per common share computations:
Basic

 

14,527

 

 

14,323

 

 

14,474

 

 

14,290

 

Diluted

 

14,527

 

 

14,323

 

 

14,474

 

 

14,290

 

 
*As described in the 2024 Annual Report, certain line items have been revised to correct an error related to the reversal of revenue from customers that was recognized improperly during 2023. These revisions increased revenue for the three and nine months ended September 30, 2024 by $0.9 million and $2.6 million, respectively. These revisions had no cash flow consequences.
TruBridge, Inc.
Condensed Consolidated Balance Sheets
(In ‘000s, except per share data)
 

September 30, 2025

(Unaudited)

 

December 31,

2024

Assets
Current assets
Cash and cash equivalents

$

19,920

 

$

12,324

 

Accounts receivable, net of allowance for expected credit losses of $4,911 and $5,861

 

56,771

 

 

53,753

 

Current portion of financing receivables, net of allowance for expected credit losses of $565 and $417

 

2,961

 

 

4,663

 

Inventories

 

351

 

 

767

 

Prepaid income taxes

 

8,602

 

 

2,886

 

Prepaid expenses and other current assets

 

13,521

 

 

15,275

 

Assets held for sale

 

445

 

 

606

 

Total current assets

 

102,571

 

 

90,274

 

 
Property & equipment, net

 

2,204

 

 

2,294

 

Software development costs, net

 

44,226

 

 

41,474

 

Operating lease right-of-use assets

 

2,391

 

 

3,092

 

Financing receivables, less current portion, less allowance for expected credit losses of $233 and $21

 

64

 

 

232

 

Other assets, less current portion

 

7,820

 

 

7,786

 

Intangible assets, net

 

67,563

 

 

76,707

 

Goodwill

 

172,573

 

 

172,573

 

Total assets

$

399,412

 

$

394,432

 

 
Liabilities & Stockholders’ Equity
Current liabilities
Accounts payable

$

20,238

 

$

15,040

 

Current portion of long-term debt

 

2,980

 

 

2,980

 

Deferred revenue

 

8,197

 

 

10,653

 

Accrued vacation

 

5,091

 

 

4,770

 

Income taxes payable

 

798

 

 

3,538

 

Other accrued liabilities

 

16,445

 

 

15,994

 

Total current liabilities

 

53,749

 

 

52,975

 

 
Long-term debt, less current portion

 

161,363

 

 

168,598

 

Operating lease liabilities, less current portion

 

1,588

 

 

2,293

 

Deferred tax liabilities

 

2,354

 

 

1,871

 

Total liabilities

 

219,054

 

 

225,737

 

 
Stockholders’ Equity
Common stock, $0.001 par value; 30,000 shares authorized; 15,690 and 15,522 shares issued

 

15

 

 

15

 

Additional paid-in capital

 

206,164

 

 

201,066

 

Retained deficit

 

(6,311

)

 

(14,952

)

Accumulated other comprehensive income

 

(91

)

 

45

 

Treasury stock, 689 and 619 shares

 

(19,419

)

 

(17,479

)

Total stockholders’ equity

 

180,358

 

 

168,695

 

 
Total liabilities and stockholders’ equity

$

399,412

 

$

394,432

 

TruBridge, Inc.
Condensed Consolidated Statements of Cash Flows
(In ‘000s)
(Unaudited)

 

 

 

Nine Months Ended September 30,

2025

 

2024 *

Operating activities:
Net income (loss)

$

8,641

 

$

(15,390

)

Adjustments to net income (loss):
Provision for credit losses

 

1,629

 

 

1,046

 

Deferred taxes

 

481

 

 

915

 

Stock-based compensation

 

5,098

 

 

3,698

 

Depreciation

 

846

 

 

1,079

 

Gain on sale of business

 

(53

)

 

(1,221

)

Amortization of acquisition-related intangibles

 

9,144

 

 

9,379

 

Amortization of software development costs

 

9,757

 

 

11,779

 

Amortization of deferred finance costs

 

390

 

 

320

 

Change in fair value of contingent consideration

 

 

 

(1,044

)

Non-cash operating lease costs

 

791

 

 

1,879

 

(Gain) loss on disposal of property and equipment

 

(120

)

 

1,648

 

Changes in operating assets and liabilities:
Accounts receivable

 

(4,317

)

 

336

 

Financing receivables

 

1,570

 

 

(129

)

Inventories

 

416

 

 

(449

)

Prepaid expenses and other assets

 

(810

)

 

3,228

 

Accounts payable

 

5,648

 

 

3,925

 

Deferred revenue

 

(2,456

)

 

2,162

 

Operating lease liabilities

 

(807

)

 

(1,415

)

Other liabilities

 

712

 

 

(189

)

Income taxes, net

 

(8,453

)

 

282

 

Net cash provided by operating activities

 

28,107

 

 

21,839

 

 
Investing activities:
Purchase of business, net of cash acquired

 

 

 

(664

)

Sale of business, net of cash and cash equivalent sold

 

2,102

 

 

21,410

 

Proceeds from sale of property and equipment

 

300

 

 

 

Investment in software development

 

(12,509

)

 

(13,666

)

Purchases of property and equipment

 

(839

)

 

(1,277

)

Net cash (used in) provided by investing activities

 

(10,946

)

 

5,803

 

 
Financing activities:
Payments of long-term debt principal

 

(2,625

)

 

(6,625

)

Proceeds from revolving line of credit

 

15,368

 

 

23,765

 

Payments of revolving line of credit

 

(20,368

)

 

(39,072

)

Debt issuance cost

 

 

 

(529

)

Treasury stock purchases

 

(1,940

)

 

(402

)

Net cash used in financing activities

 

(9,565

)

 

(22,863

)

 
Increase in cash and cash equivalents

 

7,596

 

 

4,779

 

 
Change in cash and cash equivalents included in assets sold

 

 

 

(41

)

Cash and cash equivalents, beginning of period

 

12,324

 

 

3,848

 

Cash and cash equivalents, end of period

$

19,920

 

$

8,586

 

 
*As described in the 2024 Annual Report, certain line items have been revised to correct an error related to the reversal of revenue from customers that was recognized improperly during 2023. These revisions increased revenue for the nine months ended September 30, 2024 by $2.6 million. These revisions had no cash flow consequences.
TruBridge, Inc.
Consolidated Bookings
(In ‘000s)
(Unaudited)

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

In ‘000s

2025

2024

 

2025

2024

Financial Health(1)

$

9,507

$

12,496

$

35,992

$

40,346

Patient Care(2)

 

5,996

 

8,454

 

27,105

 

27,464

 
Total Bookings

$

15,503

$

20,950

$

63,097

$

67,810

 

(1)

Generally calculated as the annual contract value

(2)

Generally calculated as the total contract value for system sales and SaaS, and annual contract value for maintenance and support
 
Annual Contract Value
Effective January 2025, the Company will be providing bookings on an Annual Contract Value (“ACV”) basis in addition to the reported bookings amounts, which has historically represented a mix of ACV and Total Contract Value (“TCV”) for Patient Care. This new methodology of reporting total bookings at ACV represents the newly contracted revenue that is expected to be recognized over a twelve-month period. Over the course of 2025, the Company will be providing total bookings under both methodologies for year over year comparability before fully transitioning to ACV in 2026.
 
The below table represents bookings at the ACV methodology for the three and nine months ended September 30, 2025:
 

Three Months Ended

September 30,

Nine Months Ended

September 30,

In ‘000s

2025

2025

Financial Health

$

9,507

$

35,992

Patient Care

 

5,545

 

16,026

 
Total Bookings (ACV)

$

15,052

$

52,018

TruBridge, Inc.
Bookings Composition
(In ‘000s, except per share data)
(Unaudited)
 

Three Months Ended September 30,

 

Nine Months Ended September 30,

In ‘000s

2025

2024

 

2025

2024

Financial Health
Net new(1)

$

1,635

$

6,112

$

13,164

$

21,559

Cross-sell(1)

 

7,872

 

6,384

 

22,828

 

18,787

Patient Care
Non-subscription sales(2)

 

3,941

 

5,006

 

9,273

 

12,540

Subscription revenue(3)

 

2,055

 

3,448

 

17,832

 

14,924

 
Total Bookings

$

15,503

$

20,950

$

63,097

$

67,810

 

(1)

“Net new” represents bookings from outside the Company’s core client base, and “Cross-sell” represents bookings from existing customers. In each case, such bookings are generally comprised of recurring revenues to be recognized ratably over a one-year period and an average timeframe for bookings-to-revenue conversion of four to six months following contract execution.

(2)

Represents nonrecurring revenues that generally exhibit a timeframe for bookings-to-revenue conversion of five to six months following contract execution.

(3)

Represents recurring revenues to be recognized on a monthly basis over a weighted-average contract period of five years, with a start date in the next 12 months and an average timeframe for commencement of bookings-to-revenue conversion of five to six months following contract execution.
 
 
Annual Contract Value
Effective January 2025, the Company will be providing bookings on an Annual Contract Value (“ACV”) basis in addition to the reported bookings amounts, which has historically represented a mix of ACV and Total Contract Value (“TCV”) for Patient Care. This new methodology of reporting total bookings at ACV represents the newly contracted revenue that is expected to be recognized over a twelve-month period. Over the course of 2025, the Company will be providing total bookings under both methodologies for year over year comparability before fully transitioning to ACV in 2026.
 
The below table represents bookings at the ACV methodology for the three and nine months ended September 30, 2025:
 

Three Months Ended

September 30,

Nine Months Ended

September 30,

In ‘000s

2025

2025

Financial Health
Net new(1)

$

1,635

$

13,164

Cross-sell(1)

 

7,872

 

22,828

Patient Care
Non-subscription sales(2)

 

3,941

 

9,274

Subscription revenue(3)

 

1,604

 

6,752

 
Total Bookings (ACV)

$

15,052

$

52,018

TruBridge, Inc.
Adjusted EBITDA – by Segment
(In ‘000s)
(Unaudited) (Non-GAAP)
 

Three Months Ended September 30,

 

Nine Months Ended September 30,

In ‘000s

2025

2024 *

 

2025

2024 *

Financial Health

$

8,872

9,964

$

27,244

$

24,970

Patient Care

 

7,400

4,728

 

21,001

 

13,490

 
Total Adjusted EBITDA

$

16,272

14,692

$

48,245

$

38,460

 
*As described in the 2024 Annual Report, certain line items have been revised to correct an error related to the reversal of revenue from customers that was recognized improperly during 2023. These revisions increased revenue for the three and nine months ended September 30, 2024 by $0.9 million and $2.6 million, respectively. These revisions had no cash flow consequences.
TruBridge, Inc.
Reconciliation of Non-GAAP Financial Measures
(In ‘000s)
(Unaudited)
 

Three Months Ended September 30,

 

Nine Months Ended September 30,

Adjusted EBITDA:

2025

 

2024 *

 

2025

 

2024 *

Net income (loss), as reported

$

5,602

 

$

(9,148

)

$

8,641

 

$

(15,390

)

Net Income (Loss) Margin

 

6.5

%

 

(10.8

%)

 

3.3

%

 

(6.0

%)

 
(Benefit from) provision for income taxes

 

(4,250

)

 

7,553

 

 

(1,670

)

 

4,257

 

Income (loss) before taxes, as reported

 

1,352

 

 

(1,595

)

 

6,971

 

 

(11,133

)

 
Depreciation expense

 

243

 

 

279

 

 

846

 

 

1,079

 

Amortization of software development costs

 

3,440

 

 

3,057

 

 

9,757

 

 

11,779

 

Amortization of acquisition-related intangibles

 

3,046

 

 

3,126

 

 

9,144

 

 

9,379

 

Stock-based compensation

 

1,788

 

 

1,398

 

 

5,098

 

 

3,698

 

Severance and other nonrecurring charges

 

3,687

 

 

4,018

 

 

7,545

 

 

12,449

 

Interest expense and other, net

 

2,716

 

 

3,777

 

 

9,057

 

 

11,826

 

Change in fair value of contingent consideration

 

 

 

(1,044

)

 

 

 

(1,044

)

Loss (gain) on disposal of property and equipment

 

 

 

1,648

 

 

(120

)

 

1,648

 

Loss (gain) on sale of AHT

 

 

 

28

 

 

(53

)

 

(1,221

)

 
Total Adjusted EBITDA

$

16,272

 

$

14,692

 

$

48,245

 

$

38,460

 

Adjusted EBITDA Margin

 

18.9

%

 

17.3

%

 

18.6

%

 

15.1

%

 
*As described in the 2024 Annual Report, certain line items have been revised to correct an error related to the reversal of revenue from customers that was recognized improperly during 2023. These revisions increased revenue for the three and nine months ended September 30, 2024 by $0.9 million and $2.6 million, respectively. These revisions had no cash flow consequences.
TruBridge, Inc.
Reconciliation of Non-GAAP Financial Measures
(In ‘000s, except per share data)
(Unaudited)
 

Three Months Ended September 30,

 

Nine Months Ended September 30,

Non-GAAP Net Income (Loss) and Non-GAAP EPS:

2025

 

2024 *

 

2025

 

2024 *

Net income (loss), as reported

$

5,602

 

$

(9,148

)

$

8,641

 

$

(15,390

)

 
Pre-tax adjustments for Non-GAAP EPS:
Amortization of acquisition-related intangible assets

 

3,046

 

 

3,126

 

 

9,144

 

 

9,379

 

Stock-based compensation

 

1,788

 

 

1,398

 

 

5,098

 

 

3,698

 

Severance and other nonrecurring charges

 

3,687

 

 

4,018

 

 

7,545

 

 

12,449

 

Non-cash interest expense

 

130

 

 

107

 

 

390

 

 

320

 

(Gain) loss on sale of AHT

 

 

 

28

 

 

(53

)

 

(1,221

)

Change in fair value of contingent consideration

 

 

 

(1,044

)

 

 

 

(1,044

)

After-tax adjustments for Non-GAAP EPS:
Tax-effect of pre-tax adjustments, at 21%

 

(1,441

)

 

(1,603

)

 

(3,575

)

 

(4,952

)

Tax windfall from stock-based compensation

 

 

 

13

 

 

(670

)

 

126

 

 
Non-GAAP net income (loss)

$

12,812

 

$

(3,105

)

$

26,520

 

$

3,365

 

 
Weighted average shares outstanding, diluted

 

14,527

 

 

14,323

 

 

14,474

 

 

14,290

 

 
Non-GAAP EPS

$

0.88

 

$

(0.22

)

$

1.83

 

$

0.24

 

 
*As described in the 2024 Annual Report, certain line items have been revised to correct an error related to the reversal of revenue from customers that was recognized improperly during 2023. These revisions increased revenue for the three and nine months ended September 30, 2024 by $0.9 million and $2.6 million, respectively. These revisions had no cash flow consequences.
TruBridge, Inc.
Revenue Composition
(In ‘000s)
(Unaudited)

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

2025

 

2024 *

 

2025

 

2024 *

Recurring revenues
Financial Health

$

53,514

$

53,513

$

162,100

$

158,426

Patient Care

 

27,425

 

27,052

 

82,988

 

82,730

Total recurring revenues

 

80,939

 

80,565

 

245,088

 

241,156

 
Non-recurring revenues
Financial Health

 

987

 

1,159

 

2,818

 

4,194

Patient Care

 

4,180

 

2,976

 

11,137

 

9,066

Total non-recurring revenues

 

5,167

 

4,135

 

13,955

 

13,260

 
Total revenues

$

86,106

$

84,700

$

259,043

$

254,416

 
*As described in the 2024 Annual Report, certain line items have been revised to correct an error related to the reversal of revenue from customers that was recognized improperly during 2023. These revisions increased revenue for the three and nine months ended September 30, 2024 by $0.9 million and $2.6 million, respectively. These revisions had no cash flow consequences.

Explanation of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States of America, or “GAAP.” However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures that are prepared in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management uses these non-GAAP financial measures in order to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. In addition, management understands that some investors and financial analysts find these non-GAAP financial measures helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the third quarter of 2025 or the fiscal year 2025 to net income for such periods, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA.

As such, to supplement the GAAP information provided, we present in this press release and during the live webcast discussing our financial results the following non-GAAP financial measures: Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net income (loss), and Non-GAAP earnings per share (“EPS”).

We calculate each of these non-GAAP financial measures as follows:

  • Adjusted EBITDA – Adjusted EBITDA consists of GAAP net income as reported and adjusts for (i) the provision for (benefit from) income taxes; (ii) depreciation expense; (iii) amortization of software development costs; (iv) amortization of acquisition-related intangibles; (v) stock-based compensation; (vi) severance and other nonrecurring charges; (vii) interest expense and other income; (viii) change in fair value of contingent consideration; (ix) (gain) loss on disposal of property and equipment; and (x) (gain) loss on sale of AHT.
  • Adjusted EBITDA Margin – Adjusted EBITDA Margin is calculated as Adjusted EBITDA, as defined above, divided by total revenue.
  • Non-GAAP net income (loss) – Non-GAAP net income (loss) consists of GAAP net income (loss) as reported and adjusts for (i) amortization of acquisition-related intangible assets; (ii) stock-based compensation; (iii) severance and other nonrecurring charges; (iv) non-cash interest expense; (v) (gain) loss on sale of AHT; (vi) change in fair value of contingent consideration, and (vii) the total tax effect of items (i) through (vi).
  • Non-GAAP EPS – Non-GAAP EPS consists of Non-GAAP net income (loss), as defined above, divided by weighted average shares outstanding (diluted) in the applicable period.

Certain of the items excluded or adjusted to arrive at these non-GAAP financial measures are described below:

  • Amortization of acquisition-related intangibles – Acquisition-related amortization expense is a non-cash expense arising primarily from the acquisition of intangible assets in connection with acquisitions or investments. We exclude acquisition-related amortization expense from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired intangible assets. Investors should note that the use of these intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation, and the related amortization expense will recur in future periods.
  • Stock-based compensation – Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards. We exclude stock-based compensation expense from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of the timing and valuation of grants of new stock-based awards, including grants in connection with acquisitions. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods, and such expense will recur in future periods.
  • Severance and other nonrecurring charges – Non-recurring charges relate to certain severance and other charges incurred in connection with activities that are considered non-recurring. We exclude non-recurring expenses (primarily related to costs associated with our recent business transformation initiative and transaction-related costs) from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods.
  • Non-cash Interest expense – Non-cash interest expense includes amortization of deferred debt issuance costs. We exclude non-cash interest expense from non-GAAP financial measures because we believe these non-cash amounts relate to specific transactions and, as such, may not directly correlate to the underlying performance of our business operations.
  • Interest expense and other, net – Interest expense and other income represents (i) interest incurred on our term loan and revolving credit facility and (ii) non-cash interest expense. We exclude interest expense from non-GAAP financial measures because we believe these amounts relate to specific transactions and, as such, may not directly correlate to the underlying performance of our business operations.
  • (Gain) loss on disposal of property and equipment – Gain on disposal of property and equipment represents the excess of proceeds received over the book value of assets disposed of during the period. We exclude gain on disposal of property and equipment from non-GAAP financial measures because we believe (i) the amount of such gain or loss in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such gain or loss can vary significantly between periods.
  • (Gain) loss on sale of AHT – Gain on sale of AHT represents the excess of proceeds received over the net assets sold from our sale of AHT, our previously wholly-owned post-acute business, in January 2024. We excluded gain on sale of AHT from non-GAAP financial measures because we believe the amount relates to a specific transaction and, as such, may not directly correlate to the underlying performance of our business operations.
  • Change in fair value of contingent consideration: The purchase agreement for our acquisition of Viewgol in 2023 contained contingent consideration, or “earnout,” provisions whereby the previous shareholders of Viewgol would receive additional consideration depending on the achievement of certain performance metrics. After the initial measurement period, U.S. GAAP requires that any adjustments to the estimated fair value of this contingent liability, including upon final determination of amounts due, should be recorded in the relevant period’s earnings. We exclude gains on contingent consideration from non-GAAP financial measures because we believe (i) the amount of such gains in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such gains can vary significantly between periods.
  • Tax shortfall (windfall) from stock-based compensation – ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, became effective for the Company during the third quarter of 2017 and changes the treatment of tax shortfall and excess tax benefits arising from stock based compensation arrangements. Prior to ASU 2016-09, these amounts were recorded as an increase (for excess benefits) or decrease (for shortfalls) to additional paid-in capital. With the adoption of ASU 2016-09, these amounts are now captured in the period’s income tax expense. We exclude this component of income tax expense from non-GAAP financial measures because we believe (i) the amount of such expenses or benefits in any specific period may not directly correlate to the underlying performance of our business operations; and (ii) such expenses or benefits can vary significantly between periods as a result of the valuation of grants of new stock-based awards, the timing of vesting of awards, and periodic movements in the fair value of our common stock.

Management considers these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance. In addition, management may use Adjusted EBITDA, Non-GAAP net income and/or Non-GAAP EPS to measure the achievement of performance objectives under the Company’s stock and cash incentive programs. Note, however, that these non-GAAP financial measures are performance measures only, and they do not provide any measure of cash flow or liquidity. Non-GAAP financial measures are not alternatives for measures of financial performance prepared in accordance with GAAP and may be different from similarly titled non-GAAP measures presented by other companies, limiting their usefulness as comparative measures. Non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Additionally, there is no certainty that we will not incur expenses in the future that are similar to those excluded in the calculations of the non-GAAP financial measures presented in this press release. Investors and potential investors are encouraged to review the “Unaudited Reconciliation of Non-GAAP Financial Measures” above.

Investor Relations Contact

Asher Dewhurst, ICR Healthcare

[email protected]

Media Contact

Tracey Schroeder

Chief Marketing Officer

[email protected]

KEYWORDS: Alabama United States North America

INDUSTRY KEYWORDS: Software Practice Management Managed Care Health Data Management Hospitals Health Technology Technology

MEDIA:

Logo
Logo

BeautyHealth Reports Third Quarter 2025 Financial Results

LONG BEACH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the “Company”), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2025 (“Q3 2025”).

“Our third-quarter results reflect disciplined execution and the continued strengthening of BeautyHealth’s foundation,” said BeautyHealth President and CEO, Pedro Malha. “Revenue of $70.7 million and Adjusted EBITDA of $8.9 million exceeded the top end of our guidance range, supported by ongoing operational efficiency. While device sales remained under pressure, the recurring consumables business continued to demonstrate resilience and profitability. With a large installed base, a growing global community of providers, and a category-defining brand in Hydrafacial, we believe we have the right foundation to drive sustainable, profitable growth. The team remains focused on expanding the device footprint, growing consumables, strengthening commercial execution, and maintaining disciplined capital stewardship.”

Key Operational and Business Metrics

  Three Months Ended September 30,   Nine Months Ended September 30,
Unaudited ($ in millions)

(1)
2025
  2024
  2025
  2024
Delivery Systems net sales $ 20.8     $ 27.6     $ 63.4     $ 98.6  
Consumables net sales   49.8       51.2       155.0       152.2  
Total net sales $ 70.7     $ 78.8     $ 218.4     $ 250.8  
Gross profit $ 45.6     $ 40.6     $ 143.3     $ 130.0  
Gross margin   64.6 %     51.6 %     65.6 %     51.8 %
Adjusted gross profit (2) $ 48.1     $ 54.7     $ 149.6     $ 151.2  
Adjusted gross margin (2)   68.0 %     69.5 %     68.5 %     60.3 %
Net loss $ (11.0 )   $ (18.3 )   $ (1.4 )   $ (18.8 )
Adjusted EBITDA (2) $ 8.9     $ 8.1     $ 30.1     $ 3.2  
Adjusted EBITDA margin (2)   12.6 %     10.2 %     13.8 %     1.3 %

  Three Months Ended September 30,


  Nine Months Ended September 30,


Unaudited 2025


  2024


  2025


  2024


Total delivery systems sold 875     1,118     2,694     3,820  
Active install base (3) 35,409     34,162     35,409     34,162  

__________________________

(1) Amounts may not sum due to rounding.
(2) See “Non-GAAP Financial Measures” below.
(3) Estimated number of delivery systems owned by providers that have purchased consumables in the trailing twelve-month period.
   

Third
Quarter Financial Highlights

  • Net sales were $70.7 million for the third quarter of 2025, a decrease of (10.3)%, compared to the prior year period (“Q3 2024”), due to lower delivery systems and consumables net sales.
  • Gross margin was 64.6% in Q3 2025, compared to 51.6% in Q3 2024. The improvement in gross margin was primarily due to lower inventory related charges and favorable mix shift towards consumable net sales, partially offset by lower average selling price of equipment net sales.
  • Adjusted gross margin was 68.0% in Q3 2025, compared to 69.5% in Q3 2024. The change in adjusted gross margin was primarily due to lower average selling price of equipment net sales.
  • Net loss was $(11.0) million in Q3 2025, compared to $(18.3) million in Q3 2024. The change compared to the prior year was primarily due to lower operational spend and higher gross margin, partially offset by lower net sales.
  • Adjusted EBITDA was $8.9 million in Q3 2025, compared to $8.1 million in Q3 2024. The improvement in adjusted EBITDA was primarily due to lower operational spend partially offset by lower adjusted gross profit.
  • The Company placed 875 delivery systems during Q3 2025, compared to 1,118 during Q3 2024, reflecting a challenging macroeconomic environment.

Balance Sheet and Cash Flow Highlights

  • Cash, cash equivalents, and restricted cash were approximately $219 million as of September 30, 2025, compared to approximately $370 million as of December 31, 2024. The change was primarily due to the repurchase of convertible senior notes during the first half of 2025.
  • The Company had approximately 7 million private placement warrants and approximately 127 million shares of Class A common stock outstanding as of September 30, 2025.

Updated 2025 Financial Guidance

Fiscal Year 2025    
Net sales $293 – $300 million  
Adjusted EBITDA (1) $37 – $39 million  

__________________________

(1) See “Non-GAAP Financial Measures” below.
   

Updated 2025 financial guidance reflects the following assumptions:

  • Increase in full-year guidance reflects improvements in Adjusted EBITDA and other financial metrics.
  • No further material deterioration in current general market conditions or other unforeseen circumstances beyond the Company’s control, such as foreign currency exchange rates, tariffs, and trade restrictions.
  • Excludes any unannounced acquisitions, dispositions or financings.

Regional
Operational and Business Metrics

  Three Months Ended September 30,


  Nine Months Ended September 30,


Unaudited ($ in millions)

(1)


(


2)
2025


  2024


  2025


  2024


Delivery Systems net sales                      
Americas $ 13.6     $ 16.2     $ 40.3     $ 54.1  
Asia-Pacific (“APAC”)   2.1       4.9       6.6       18.9  
Europe, the Middle East and Africa (“EMEA”)   5.1       6.5       16.5       25.6  
Total Delivery Systems net sales $ 20.8     $ 27.6     $ 63.4     $ 98.6  
                       
Consumables net sales                      
Americas $ 34.7     $ 35.6     $ 106.3     $ 105.8  
APAC   4.2       5.9       15.8       17.5  
EMEA   10.9       9.6       32.9       28.9  
Total Consumables net sales $ 49.8     $ 51.2     $ 155.0     $ 152.2  
                       
Net sales                      
Americas $ 48.3     $ 51.9     $ 146.6     $ 159.9  
APAC   6.3       10.8       22.4       36.4  
EMEA   16.1       16.1       49.5       54.4  
Total net sales $ 70.7     $ 78.8     $ 218.4     $ 250.8  
                       
Delivery Systems sold                      
Americas   540       634       1,649       2,046  
APAC   123       215       358       771  
EMEA   212       269       687       1,003  
Total Delivery Systems sold   875       1,118       2,694       3,820  

__________________________

(1) Amounts may not sum due to rounding.
(2) During the second quarter of 2025, the Company transitioned sales in the China market to a distributor partner, and as a result, the Company has discontinued direct sales to customers in China.
   

Conference Call

BeautyHealth will host a conference call on Thursday, November 6, 2025, at 4:30 p.m. ET to review its third quarter 2025 financial results. The call may be accessed via live webcast through the Events & Presentations page on our Investor Relations website at https://investors.beautyhealth.com. A replay of the conference call will be available approximately three hours after the conclusion of the call and can be accessed online at https://investors.beautyhealth.com.

Non-GAAP Financial Measures

In addition to results determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”), management utilizes certain non-GAAP financial measures such as adjusted gross profit, adjusted gross margin, adjusted EBITDA, and adjusted EBITDA margin for purposes of evaluating ongoing operations and for internal planning and forecasting purposes.

Management believes that these non-GAAP financial measures, when reviewed collectively with the Company’s GAAP financial information, provide useful supplemental information to investors in assessing the Company’s operating performance. These non-GAAP financial measures should not be considered as an alternative to GAAP financial information or as an indication of operating performance or any other measure of performance derived in accordance with GAAP, and may not provide information that is directly comparable to that provided by other companies in its industry, as these other companies may calculate non-GAAP financial measures differently, particularly related to unusual items.

Adjusted gross profit is gross profit excluding the effects of depreciation expense, amortization expense, share-based compensation expense, manufacturing optimization costs, and write-off of discontinued, excess and obsolete product. Adjusted gross margin represents adjusted gross profit as a percentage of net sales.

Adjusted EBITDA is calculated as net loss excluding the effects of expense for income taxes; depreciation expense; amortization expense; share-based compensation expense; interest expense; interest income; other income, net; change in fair value of warrant liabilities; foreign currency loss (gain), net; litigation related costs; Go-to-Market restructuring; manufacturing optimization costs; write-off of discontinued, excess and obsolete product; and severance, restructuring and other. Adjusted EBITDA margin represents adjusted EBITDA as a percentage of net sales.

The Company does not provide a reconciliation of its fiscal 2025 adjusted EBITDA guidance to net loss, the most directly comparable forward looking GAAP financial measures, due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, which cannot be done without unreasonable efforts, including adjustments that could be made for changes in fair value of warrant liabilities, integration and acquisition-related expenses, amortization expenses, non-cash share-based compensation, gains/losses on foreign currency, and other charges reflected in our reconciliation of historic numbers, the amount of which, based on historical experience, could be significant. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. The Company’s fiscal 2025 adjusted EBITDA guidance is merely an outlook and is not a guarantee of future performance. Stockholders should not rely or place an undue reliance on such forward-looking statements. See “Forward-Looking Statements” for additional information.

The Beauty Health Company
Condensed Consolidated Statements of Comprehensive Income (Loss) (1)
($ in millions, except share and per share amounts)
(Unaudited)



       
  Three Months Ended September 30,   Nine Months Ended September 30,
  2025   2024   2025   2024
Net sales $ 70.7     $ 78.8     $ 218.4     $ 250.8  
Cost of sales   25.0       38.2       75.1       120.8  
Gross profit   45.6       40.6       143.3       130.0  
Operating expenses:                              
Selling and marketing   20.9       27.6       70.1       91.8  
Research and development   1.7       1.1       3.9       5.1  
General and administrative   29.3       33.4       90.3       93.7  
Total operating expenses   51.9       62.2       164.3       190.6  
Loss from operations   (6.2 )     (21.5 )     (21.0 )     (60.6 )
Interest expense   6.3       2.5       13.0       7.9  
Interest income   (1.3 )     (4.9 )     (7.4 )     (14.4 )
Other income, net   (0.6 )     (0.1 )     (18.8 )     (33.5 )
Change in fair value of warrant liabilities   (0.2 )     (0.4 )     (0.3 )     (3.0 )
Foreign currency transaction loss (gain), net   0.2       (2.3 )     (6.2 )     0.2  
Loss before provision for income taxes   (10.6 )     (16.3 )     (1.1 )     (17.8 )
Income tax expense   0.4       1.9       0.3       0.9  
Net loss   (11.0 )     (18.3 )     (1.4 )     (18.8 )
Comprehensive (loss) income, net of tax:              
Foreign currency translation adjustments   0.4       1.2       5.2       (0.7 )
Comprehensive (loss) income $ (10.6 )   $ (17.1 )   $ 3.8     $ (19.4 )
Net loss per share              
Basic $ (0.09 )   $ (0.15 )   $ (0.01 )   $ (0.15 )
Diluted $ (0.09 )   $ (0.15 )   $ (0.11 )   $ (0.31 )
Weighted average common shares outstanding                              
Basic   126,890,888       124,057,602       126,020,956       123,630,811  
Diluted   126,890,888       124,057,602       137,294,187       142,667,209  

__________________________

(1) Amounts may not sum due to rounding.
   

The Beauty Health Company

Condensed Consolidated
Balance Sheets

(1)


($ in millions)

(Unaudited)
       
  September 30, 2025   December 31, 2024
ASSETS      
Current assets:      
Cash, cash equivalents, and restricted cash $ 219.4     $ 370.1  
Accounts receivable, net   22.2       27.6  
Inventories   56.1       69.1  
Income tax receivable   3.2       0.8  
Prepaid expenses and other current assets   7.4       9.5  
Total current assets   308.4       477.1  
Property and equipment, net   3.1       6.0  
Right-of-use assets, net   13.6       13.6  
Intangible assets, net   38.0       47.5  
Goodwill   126.5       123.5  
Deferred income tax assets, net   1.0       3.9  
Other assets   13.1       14.1  
TOTAL ASSETS $ 503.6     $ 685.7  
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable $ 17.3     $ 21.9  
Accrued payroll-related expenses   18.8       17.6  
Lease liabilities, current   5.0       5.1  
Income tax payable   1.5       3.4  
Other accrued expenses   19.3       20.0  
Total current liabilities   61.9       68.2  
Lease liabilities, non-current   10.6       10.8  
Deferred income tax liabilities, net   0.1       0.4  
Warrant liabilities   0.1       0.5  
Convertible senior notes, net   363.4       552.2  
Other long-term liabilities   1.9       1.8  
TOTAL LIABILITIES $ 438.0     $ 633.9  
       
Stockholders’ equity:      
Class A Common Stock $     $  
Additional paid-in capital   576.8       566.7  
Accumulated other comprehensive loss   (1.8 )     (7.0 )
Accumulated deficit   (509.4 )     (508.0 )
Total stockholders’ equity $ 65.7     $ 51.8  
LIABILITIES AND STOCKHOLDERS’ EQUITY $ 503.6     $ 685.7  

__________________________

(1) Amounts may not sum due to rounding.
   

The Beauty Health Company

Condensed Consolidated
Statement of Cash Flows

(1)


($ in millions)

(Unaudited)


   
  Nine Months Ended September 30,
  2025   2024
Cash, cash equivalents, and restricted cash at beginning of period $ 370.1     $ 523.0  
Operating activities:      
Net loss   (1.4 )     (18.8 )
Non-cash adjustments:   21.2       51.6  
Change in operating assets and liabilities:      
Accounts receivable   4.8       13.3  
Inventories   11.1       (7.5 )
Prepaid expenses, other current assets, and income tax receivable   (0.1 )     8.0  
Accounts payable, accrued expenses, and income tax payable   (7.1 )     (39.5 )
Other, net   (6.2 )     (7.5 )
Net cash provided by (used for) operating activities   22.3       (0.3 )
Net cash used for investing activities   (3.8 )     (5.9 )
Net cash used for financing activities   (174.4 )     (157.6 )
Net change in cash, cash equivalents, and restricted cash   (155.9 )     (163.8 )
Effect of foreign currency translation   5.2       (0.3 )
Cash, cash equivalents, and restricted cash at end of period $ 219.4     $ 358.9  

__________________________

(1) Amounts may not sum due to rounding.
   

The following table reconciles gross profit to adjusted gross profit for the periods presented:

  Three Months Ended September 30,   Nine Months Ended September 30,
Unaudited ($ in millions)

(1)
2025   2024   2025   2024
Net sales $ 70.7     $ 78.8     $ 218.4     $ 250.8  
               
Gross profit $ 45.6     $ 40.6     $ 143.3     $ 130.0  
Gross margin   64.6 %     51.6 %     65.6 %     51.8 %
               
Adjusted to exclude the following:              
Depreciation expense   0.2       1.0       0.7       1.8  
Amortization expense   2.1       3.2       5.2       9.8  
Share-based compensation expense   0.1       0.2       0.4       (0.1 )
Manufacturing optimization costs         7.6             7.6  
Write-off of discontinued, excess and obsolete product         2.0             2.0  
Adjusted gross profit $ 48.1     $ 54.7     $ 149.6     $ 151.2  
Adjusted gross margin   68.0 %     69.5 %     68.5 %     60.3 %

__________________________

(1) Amounts may not sum due to rounding.
   

The following table reconciles net loss to adjusted EBITDA for the periods presented:

  Three Months Ended September 30,   Nine Months Ended September 30,
Unaudited ($ in millions)

(1)
2025   2024   2025   2024
Net sales $ 70.7     $ 78.8     $ 218.4     $ 250.8  
               
Net loss $ (11.0 )   $ (18.3 )   $ (1.4 )   $ (18.8 )
Adjusted to exclude the following:              
Expense for income taxes   0.4       1.9       0.3       0.9  
Depreciation expense   0.6       3.1       3.2       8.5  
Amortization expense   7.8       6.5       16.8       18.6  
Share-based compensation expense   2.5       7.7       11.2       20.8  
Interest expense   6.3       2.5       13.0       7.9  
Interest income   (1.3 )     (4.9 )     (7.4 )     (14.4 )
Other income, net   (0.6 )     (0.1 )     (18.8 )     (33.5 )
Change in fair value of warrant liabilities   (0.2 )     (0.4 )     (0.3 )     (3.0 )
Foreign currency loss (gain), net   0.2       (2.3 )     (6.2 )     0.2  
Litigation related costs   2.2       2.5       14.1       3.7  
Go-to-Market restructuring               3.0        
Manufacturing optimization costs         7.6             7.6  
Write-off of discontinued, excess and obsolete product         2.0             2.0  
Severance, restructuring and other   2.1       0.2       2.7       2.5  
Adjusted EBITDA $ 8.9     $ 8.1     $ 30.1     $ 3.2  
Adjusted EBITDA margin   12.6 %     10.2 %     13.8 %     1.3 %

__________________________

(1) Amounts may not sum due to rounding.
   

About The Beauty Health Company

The Beauty Health Company (NASDAQ: SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in nanoneedling and microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/, and learn more at beautyhealth.com or LinkedIn.

Forward-Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding The Beauty Health Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside The Beauty Health Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

Important factors that may affect actual results or outcomes include, among others: The Beauty Health Company’s ability to manage growth; The Beauty Health Company’s ability to execute its business plan; potential litigation involving The Beauty Health Company; changes in applicable laws or regulations; the possibility that The Beauty Health Company may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (the “SEC”) and in the Company’s subsequent filings with the SEC such as on a Quarterly Report on Form 10-Q. There may be additional risks that the Company does not presently know of or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. The Beauty Health Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Contacts

Investors: [email protected]
Press: [email protected]



EVERTEC Reports Third Quarter 2025 Results

EVERTEC Reports Third Quarter 2025 Results

Raises full year outlook

SAN JUAN, Puerto Rico–(BUSINESS WIRE)–
EVERTEC, Inc. (NYSE: EVTC) (“Evertec” or the “Company”) today announced results for the third quarter ended September 30, 2025.

Third Quarter 2025 Highlights and Recent Highlights

  • Revenue increased 8% to $228.6 million, approximately 8% on a constant currency basis
  • GAAP Net Income attributable to common shareholders increased 33% to $32.9 million, and increased 34% to $0.51 per diluted share
  • Adjusted EBITDA increased 6% to $92.6 million and Adjusted earnings per common share increased 7% to $0.92
  • Completed the purchase of 75% of the share capital of Tecnobank Tecnologia Bancária S.A. (“Tecnobank”)

Mac Schuessler, President and Chief Executive Officer, stated, “We are pleased with our third quarter results, which reflects our continued focus on operational excellence and strategic execution. By expanding our footprint in Latin America through the Tecnobank acquisition, we’ve strengthened our platform and positioned the company for long-term growth.”

Third Quarter 2025 Results

Revenue. Total revenue for the quarter ended September 30, 2025 was $228.6 million, an increase of 8%, compared with $211.8 million in the prior year quarter driven by organic growth across all of the Company’s segments and the contribution from the acquisitions completed in the fourth quarter of 2024. Constant currency revenue amounted to $227.9 million, representing growth of 8%. Merchant acquiring revenue benefited from higher sales volume and higher non-transactional revenues, partially offset by a slight decrease in spread. Payments Puerto Rico revenue benefited from ATH Movil transaction and sales volume growth, primarily in the ATH Business. Latin America revenue benefited from strong performance in Brazil, continued organic growth across the entire region and the contribution from acquisitions completed in the prior year. Business Solutions revenue increased as a result of projects completed during the quarter and an increase in hardware sales.

Net Income attributable to common shareholders. For the quarter ended September 30, 2025, GAAP Net Income attributable to common shareholders was $32.9 million or $0.51 per diluted share, an increase of $8.2 million, compared with $24.7 million or $0.38 per diluted share in the prior year. The increase was driven by higher revenues, lower depreciation and amortization from intangible assets that became fully amortized during the prior year, lower interest expense from lower interest rates and repricing of our debt completed during the year and a $5.7 million gain on the sale of tax credits. These variances were partially offset by an increase in cost of revenues, in part driven by the recognition of estimated liabilities associated with potential contractual claims related to client losses from the Pix incident, increases in software maintenance expense and cloud expenses, an increase in personnel costs and professional services.

Adjusted EBITDA and Adjusted EBITDA Margin. For the quarter ended September 30, 2025, Adjusted EBITDA was $92.6 million, an increase of $5.2 million when compared to the prior year quarter, driven by the increase in revenues. Adjusted EBITDA margin (Adjusted EBITDA as a percentage of total revenue) decreased slightly to 40.5% compared with 41.3% in the prior year.

Adjusted Net Income and Adjusted earnings per common share. For the quarter ended September 30, 2025, Adjusted Net Income was $59.8, an increase of 8% compared with $55.4 million in the prior year, driven by the increase in Adjusted EBITDA and lower cash interest expense, as we benefited from lower interest rates and the impact from repricing our debt. This was partially offset by an increase in the adjusted effective tax rate and higher operating depreciation and amortization expense. Adjusted earnings per common share was $0.92, an increase of 7% compared with $0.86 in the prior year driven by the factors explained for Adjusted Net Income.

Business Acquisition

On October 1, 2025, Evertec completed the acquisition of 75% of Tecnobank Tecnologia Bancária, which is a leading fintech vendor in Brazil’s digital vehicle financing contract registration sector.

2025 Outlook

The Company’s revised financial outlook for 2025 is as follows:

  • We now expect revenue between $921 million and $927 million representing growth of approximately 8.9% to 9.6%, and increase from our previous expectation of 6.6% to 7.6%. Constant currency growth is now expected to be between 10.0% to 11.0%.
  • Adjusted earnings per common share is now expected to be between $3.56 to $3.62 representing growth of approximately 8.5% to 10.4%, and increase from our previous expectation of 4.8% to 7.0%. On a constant currency basis, growth is expected to be between 9.6% to 11.6%.
  • Continue to expect capital expenditures to be approximately $85 million
  • Continue to expect an adjusted effective tax rate of approximately 6% to 7%

Earnings Conference Call and Audio Webcast

The Company will host a conference call to discuss its third quarter 2025 financial results today at 4:30 p.m. ET. Hosting the call will be Mac Schuessler, President and Chief Executive Officer, Joaquin Castrillo, Chief Operating Officer, and Karla Cruz-Jusino, Chief Financial Officer. The conference call can be accessed live over the phone by dialing (888) 338-7153 or for international callers by dialing (412) 317-5117. A replay will be available one hour after the end of the conference call and can be accessed by dialing (855) 669-9658 or (412) 317-0088 for international callers; the pin number is 9184714. The replay will be available through Thursday, November 13, 2025. The call will be webcast live from the Company’s website at www.evertecinc.com under the Investor Relations section or directly at http://ir.evertecinc.com. A supplemental slide presentation that accompanies this call and webcast can be found on the investor relations website at ir.evertecinc.com and will remain available after the call.

About Evertec

EVERTEC, Inc. (NYSE: EVTC) is a leading full-service transaction processor and financial technology provider in Latin America, Puerto Rico and the Caribbean, providing a broad range of merchant acquiring, payment services and business process management services. Evertec owns and operates the ATH® network, one of the leading personal identification number (“PIN”) debit networks in Latin America. In addition, the Company manages a system of electronic payment networks and offers a comprehensive suite of services for core banking, cash processing and fulfillment in Puerto Rico, that process over ten billion transactions annually. The Company also offers financial technology outsourcing in all the regions it serves. Based in Puerto Rico, the Company operates in 26 Latin American countries and serves a diversified customer base of leading financial institutions, merchants, corporations and government agencies with “mission-critical” technology solutions. For more information, visit www.evertecinc.com.

Use of Non-GAAP Financial Information

The non-GAAP measures referenced in this earnings release are supplemental measures of the Company’s performance and are not required by, or presented in accordance with, accounting principles generally accepted in the United States of America (“GAAP”). They are not measurements of the Company’s financial performance under GAAP and should not be considered as alternatives to total revenue, net income or any other performance measures derived in accordance with GAAP or as alternatives to cash flows from operating activities, as indicators of operating performance or as measures of the Company’s liquidity. In addition to GAAP measures, management uses these non-GAAP measures to focus on the factors the Company believes are pertinent to the daily management of the Company’s operations and believes that they are also frequently used by analysts, investors and other stakeholders to evaluate companies in our industry. These measures have certain limitations in that they do not include the impact of certain expenses that are reflected in our condensed consolidated statements of operations that are necessary to run our business. Other companies, including other companies in our industry, may not use these measures or may calculate these measures differently than as presented herein, limiting their usefulness as comparative measures.

Reconciliations of the non-GAAP measures to the most directly comparable GAAP measure are included at the end of this earnings release. These non-GAAP measures include Constant currency revenue, EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings per common share, and Constant Currency Adjusted Earnings per common share, each as defined below.

Constant currency revenue represents reported revenue excluding the impact of fluctuations in foreign currency exchange rates in the current period. Constant currency revenue is calculated by applying prior-year period foreign currency exchange rates to current-period revenue.

EBITDA is defined as earnings before interest, taxes, depreciation and amortization.

Adjusted EBITDA is defined as EBITDA further adjusted to exclude certain non-cash items and unusual expenses such as: share-based compensation, restructuring related expenses, fees and expenses from corporate transactions such as M&A activity and financing, multi-year non-recurring gains recognized in connection with the sale of tax credits, equity investment income net of dividends received, and the impact from unrealized gains and losses on foreign currency remeasurement for assets and liabilities in non-functional currency. Segment Adjusted EBITDA which is the measure reported to the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing their performance, is presented in conformity with Accounting Standards Codification 280, Segment Reporting, and for this reason is excluded from the definition of non-GAAP financial measures under the Securities and Exchange Commission’s Regulation G and Item 10(e) of Regulation S-K. The Company’s presentation of Adjusted EBITDA is substantially consistent with the equivalent measurements that are contained in the secured credit facilities in testing EVERTEC Group’s compliance with covenants therein such as the secured leverage ratio. Adjusted EBITDA Margin is defined as Adjusted EBITDA as a percentage of total revenues.

Adjusted Net Income is defined as Adjusted EBITDA less: operating depreciation and amortization expense, defined as GAAP Depreciation and amortization less amortization of intangibles related to acquisitions such as customer relationships, trademarks, non-compete agreements, among others; cash interest expense defined as GAAP interest expense, less GAAP interest income adjusted to exclude non-cash amortization of debt issue costs and premiums and accretion of discount; income tax expense which is calculated on adjusted pre-tax income using the applicable GAAP tax rate, adjusted for uncertain tax position releases, tax true-ups, windfall from share-based compensation, unrealized gains and losses from foreign currency remeasurement, among others; and non-controlling interests, net of amortization for intangibles created as part of the purchase.

Adjusted Earnings per common share is defined as Adjusted Net Income divided by diluted shares outstanding.

Constant Currency Adjusted Earnings per common share is defined as Adjusted earnings per common share excluding the impact of fluctuations in foreign currency exchange rates in the current period, calculated by applying prior-year period foreign currency exchange rates to current-period results.

The Company uses Adjusted Net Income to measure the Company’s overall profitability because the Company believes it better reflects the comparable operating performance by excluding the impact of the non-cash amortization and depreciation that was created as a result of merger and acquisition activity. In addition, in evaluating EBITDA, Adjusted EBITDA, Adjusted Net Income and Adjusted Earnings per common share, you should be aware that in the future the Company may incur expenses such as those excluded in calculating them.

Forward-Looking Statements

Certain statements in this earnings release constitute “forward-looking statements” within the meaning of, and subject to the protection of, the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release other than statements of historical facts, including, without limitation, statements regarding our future results of operations and financial position, including our guidance for fiscal year 2025; our business strategies; objectives of management for future operations, including, among others, statements regarding our expected growth, international expansion and future capital expenditures; and expectations for and anticipated benefits of acquisitions, are forward looking statements. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” and “plans” and similar expressions of future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts.

Various factors that could cause actual future results and other future events to differ materially from those estimated by management include, but are not limited to: our reliance on our relationship with Popular, Inc. (“Popular”) for a significant portion of our revenues pursuant to our second Amended and Restated Master Services Agreement (“A&R MSA”) with them, and as it may impact our ability to grow our business; our ability to renew our client contracts on terms favorable to us, including but not limited to the current term and any extension of the A&R MSA with Popular and Amended and Restated Independent Sales Organization Sponsorship and Services Agreement (the “A&R ISO Agreement”) with Banco Popular; our reliance on our information technology systems, employees and certain suppliers and counterparties, and certain failures or disruptions in those systems or chains could materially adversely affect our operations; the risk of security breaches or other confidential data theft from our systems; our ability to recruit, retain and develop qualified personnel; fraud by merchants or others; the credit risk of our merchant clients, for which we may also be liable; our use of artificial intelligence (“AI”) and machine learning tools and the evolving regulatory framework governing such technology; a decreased client base due to consolidations and/or failures in the financial services industry; our ability to comply with existing and future rules and regulations in the jurisdictions in which we operate; a reduction in consumer confidence, whether as a result of a global economic downturn or otherwise, which leads to a decrease in consumer spending; our dependence on payment card network or other network rules, standards or fees; the geographical concentration of our business in Puerto Rico, including our business with the government of Puerto Rico and its instrumentalities, which are facing fiscal challenges and the effects of potential natural disasters; risks associated with our presence in international markets, including global political, social and economic instability; operating an international business in Latin America, Puerto Rico and the Caribbean, in jurisdictions with potential political and economic instability; the impact of exposure to foreign exchange fluctuations and capital controls on our costs, earnings and the value of some of our assets; our ability to protect our intellectual property rights against infringement and to defend ourselves against potential intellectual property infringement claims and the potential impact on our business of such claims, whether or not correct; the possibility that we could lose our preferential tax rate in Puerto Rico; the possibility that we may not realize the anticipated benefits of our merger with Sinqia; the effect of purchases of our common stock pursuant to our stock repurchase plan on the value of our common stock; and the impact of our leverage on our ability to raise additional capital, that our leverage may limit our ability to react to changes in the economy or our industry, expose us to interest rate risk and prevent us from meeting our obligations with respect to our substantial indebtedness, that we and our subsidiaries may be able to incur significant additional indebtedness, which could further increase such risks; and the other factors set forth under “Part 1, Item 1A. Risk Factors,” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Securities and Exchange Commission (the “SEC”) on March 3, 2025. The Company undertakes no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events unless it is required to do so by law.

 

EVERTEC, Inc.

Schedule 1: Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (Loss)

 

 

 

Three months ended

September 30,

 

Nine months ended

September 30,

(Dollar amounts in thousands, except share data)

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Revenues

 

$

228,587

 

 

$

211,795

 

 

$

686,986

 

 

$

629,091

 

 

 

 

 

 

 

 

 

 

Operating costs and expenses

 

 

 

 

 

 

 

 

Cost of revenues, exclusive of depreciation and amortization

 

 

124,742

 

 

 

102,497

 

 

 

349,411

 

 

 

302,426

 

Selling, general and administrative expenses

 

 

37,678

 

 

 

34,097

 

 

 

108,992

 

 

 

107,910

 

Depreciation and amortization

 

 

28,435

 

 

 

33,660

 

 

 

85,217

 

 

 

101,051

 

Total operating costs and expenses

 

 

190,855

 

 

 

170,254

 

 

 

543,620

 

 

 

511,387

 

Income from operations

 

 

37,732

 

 

 

41,541

 

 

 

143,366

 

 

 

117,704

 

Non-operating income (expenses)

 

 

 

 

 

 

 

 

Interest income

 

 

4,016

 

 

 

3,696

 

 

 

10,346

 

 

 

10,274

 

Interest expense

 

 

(16,534

)

 

 

(18,704

)

 

 

(50,241

)

 

 

(57,352

)

(Loss) gain on foreign currency remeasurement

 

 

(60

)

 

 

(1,112

)

 

 

455

 

 

 

(3,164

)

Earnings from equity investees

 

 

1,346

 

 

 

1,099

 

 

 

4,290

 

 

 

3,266

 

Other income, net

 

 

6,929

 

 

 

389

 

 

 

7,483

 

 

 

6,484

 

Total non-operating expenses

 

 

(4,303

)

 

 

(14,632

)

 

 

(27,667

)

 

 

(40,492

)

Income before income taxes

 

 

33,429

 

 

 

26,909

 

 

 

115,699

 

 

 

77,212

 

Income tax (benefit) expense

 

 

(31

)

 

 

1,707

 

 

 

8,175

 

 

 

3,100

 

Net income

 

 

33,460

 

 

 

25,202

 

 

 

107,524

 

 

 

74,112

 

Less: Net income attributable to non-controlling interest

 

 

599

 

 

 

524

 

 

 

1,495

 

 

 

1,554

 

Net income attributable to EVERTEC, Inc.’s common stockholders

 

 

32,861

 

 

 

24,678

 

 

 

106,029

 

 

 

72,558

 

Other comprehensive income (loss), net of tax

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

13,593

 

 

 

15,354

 

 

 

92,799

 

 

 

(75,473

)

Loss on cash flow hedges

 

 

(313

)

 

 

(11,937

)

 

 

(6,465

)

 

 

(8,555

)

Unrealized gain (loss) on change in fair value of debt securities available-for-sale

 

 

5

 

 

$

(1

)

 

$

15

 

 

$

(4

)

Other comprehensive income (loss), net of tax

 

$

13,285

 

 

$

3,416

 

 

$

86,349

 

 

$

(84,032

)

Total comprehensive income (loss) attributable to EVERTEC, Inc.’s common stockholders

 

$

46,146

 

 

$

28,094

 

 

$

192,378

 

 

$

(11,474

)

Net income per common share:

 

 

 

 

 

 

 

 

Basic

 

$

0.51

 

 

$

0.39

 

 

$

1.66

 

 

$

1.12

 

Diluted

 

$

0.51

 

 

$

0.38

 

 

$

1.64

 

 

$

1.11

 

Shares used in computing net income per common share:

 

 

 

 

 

 

 

 

Basic

 

 

63,982,424

 

 

 

63,944,132

 

 

 

63,917,639

 

 

 

64,512,868

 

Diluted

 

 

64,766,300

 

 

 

64,719,129

 

 

 

64,692,541

 

 

 

65,316,948

 

 

EVERTEC, Inc.

Schedule 2: Unaudited Condensed Consolidated Balance Sheets

 

(Dollar amounts in thousands, except share data)

 

September 30, 2025

 

December 31, 2024

Assets

 

 

 

 

Current Assets:

 

 

 

 

Cash and cash equivalents

 

$

474,738

 

 

$

273,645

 

Restricted cash

 

 

24,998

 

 

 

24,594

 

Accounts receivable, net

 

 

153,862

 

 

 

137,501

 

Settlement assets

 

 

15,000

 

 

 

31,942

 

Prepaid expenses and other assets

 

 

75,822

 

 

 

61,383

 

Total current assets

 

 

744,420

 

 

 

529,065

 

Debt securities available-for-sale, at fair value

 

 

2,595

 

 

 

913

 

Equity securities, at fair value

 

 

6,250

 

 

 

4,976

 

Investments in equity investees

 

 

29,336

 

 

 

29,472

 

Property and equipment, net

 

 

63,184

 

 

 

62,059

 

Operating lease right-of-use asset

 

 

7,475

 

 

 

10,131

 

Goodwill

 

 

779,671

 

 

 

726,901

 

Other intangible assets, net

 

 

447,943

 

 

 

430,885

 

Deferred tax asset

 

 

46,225

 

 

 

33,877

 

Derivative asset

 

 

 

 

 

4,338

 

Other long-term assets

 

 

22,068

 

 

 

24,994

 

Total assets

 

$

2,149,167

 

 

$

1,857,611

 

Liabilities and stockholders’ equity

 

 

 

 

Current Liabilities:

 

 

 

 

Accrued liabilities

 

$

136,232

 

 

$

124,553

 

Accounts payable

 

 

47,160

 

 

 

58,729

 

Contract liability

 

 

22,885

 

 

 

25,274

 

Income tax payable

 

 

7,461

 

 

 

8,981

 

Current portion of long-term debt

 

 

23,867

 

 

 

23,867

 

Current portion of operating lease liability

 

 

3,787

 

 

 

6,229

 

Settlement liabilities

 

 

14,787

 

 

 

32,027

 

Total current liabilities

 

 

256,179

 

 

 

279,660

 

Long-term debt

 

 

1,059,143

 

 

 

925,062

 

Deferred tax liability

 

 

40,981

 

 

 

44,810

 

Contract liability – long term

 

 

48,908

 

 

 

55,003

 

Operating lease liability – long-term

 

 

4,597

 

 

 

4,924

 

Derivative liability

 

 

5,155

 

 

 

1,351

 

Other long-term liabilities

 

 

26,187

 

 

 

27,540

 

Total liabilities

 

 

1,441,150

 

 

 

1,338,350

 

Redeemable non-controlling interests

 

 

41,282

 

 

 

43,460

 

Stockholders’ equity

 

 

 

 

Preferred stock, par value $0.01; 2,000,000 shares authorized; none issued

 

 

 

 

 

 

Common stock, par value $0.01; 206,000,000 shares authorized; 63,983,841 shares issued and outstanding as of September 30, 2025 (December 31, 2024 – 63,614,077)

 

 

640

 

 

 

636

 

Additional paid-in capital

 

 

15,429

 

 

 

7,003

 

Accumulated earnings

 

 

696,055

 

 

 

599,608

 

Accumulated other comprehensive loss, net of tax

 

 

(48,374

)

 

 

(134,723

)

Total EVERTEC, Inc. stockholders’ equity

 

 

663,750

 

 

 

472,524

 

Non-controlling interest

 

 

2,985

 

 

 

3,277

 

Total equity

 

 

666,735

 

 

 

475,801

 

Total liabilities and equity

 

$

2,149,167

 

 

$

1,857,611

 

 

EVERTEC, Inc.

Schedule 3: Unaudited Condensed Consolidated Statements of Cash Flows

 

 

 

Nine months ended September 30,

(In thousands)

 

 

2025

 

 

 

2024

 

Cash flows from operating activities

 

 

 

 

Net income

 

$

107,524

 

 

$

74,112

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

 

85,217

 

 

 

101,051

 

Amortization of debt issue costs and accretion of discount

 

 

2,770

 

 

 

3,576

 

Operating lease amortization

 

 

5,373

 

 

 

5,340

 

Provision (release) for expected credit losses and sundry losses

 

 

9,455

 

 

 

(476

)

Deferred tax benefit

 

 

(18,944

)

 

 

(20,275

)

Share-based compensation

 

 

22,194

 

 

 

22,387

 

Gain on sale of equity securities

 

 

 

 

 

(2,599

)

Earnings of equity investees

 

 

(4,290

)

 

 

(3,266

)

Dividend received from equity method investee

 

 

3,861

 

 

 

3,364

 

(Gain) loss on foreign currency remeasurement

 

 

(455

)

 

 

3,164

 

Other, net

 

 

821

 

 

 

189

 

(Increase) decrease in assets:

 

 

 

 

Accounts receivable, net

 

 

(19,332

)

 

 

(838

)

Prepaid expenses and other assets

 

 

(10,890

)

 

 

(1,791

)

Other long-term assets

 

 

3,160

 

 

 

3,247

 

(Decrease) increase in liabilities:

 

 

 

 

Accrued liabilities and accounts payable

 

 

(18,249

)

 

 

(12,046

)

Income tax payable

 

 

(2,366

)

 

 

2,359

 

Contract liability

 

 

(9,690

)

 

 

12,038

 

Operating lease liabilities

 

 

(5,626

)

 

 

(5,341

)

Other long-term liabilities

 

 

6,468

 

 

 

702

 

Total adjustments

 

 

49,477

 

 

 

110,785

 

Net cash provided by operating activities

 

 

157,001

 

 

 

184,897

 

Cash flows from investing activities

 

 

 

 

Additions to software and other intangible assets

 

 

(50,905

)

 

 

(48,778

)

Property and equipment acquired

 

 

(17,020

)

 

 

(21,050

)

Acquisition of available-for-sale debt securities

 

 

(1,782

)

 

 

 

Investment in equity investee

 

 

 

 

 

(2,000

)

Proceeds from maturities of available-for-sale debt securities

 

 

1,000

 

 

 

370

 

Proceeds from sale of equity securities

 

 

 

 

 

6,128

 

Other investing activities, net

 

 

(896

)

 

 

(132

)

Net cash used in investing activities

 

 

(69,603

)

 

 

(65,462

)

Cash flows from financing activities

 

 

 

 

Acquisition of redeemable non-controlling interest

 

 

(5,167

)

 

 

 

Withholding taxes paid on share-based compensation

 

 

(8,942

)

 

 

(9,907

)

Borrowings under Revolving Facility

 

 

150,000

 

 

 

 

Dividends paid

 

 

(9,582

)

 

 

(9,692

)

Repurchase of common stock

 

 

(3,691

)

 

 

(82,293

)

Repayment of long-term debt

 

 

(17,900

)

 

 

(17,900

)

Repayment of other financing agreements

 

 

(4,478

)

 

 

(7,046

)

Settlement activity, net

 

 

(8,167

)

 

 

209

 

Other financing activities, net

 

 

(2,958

)

 

 

(3,652

)

Net cash provided by (used in) financing activities

 

 

89,115

 

 

 

(130,281

)

Effect of foreign exchange rate on cash, cash equivalents and restricted cash

 

 

16,817

 

 

 

(6,596

)

Net increase (decrease) in cash, cash equivalents, restricted cash and cash included in settlement assets

 

 

193,330

 

 

 

(17,442

)

Cash, cash equivalents, restricted cash and cash included in settlement assets at the beginning of the period

 

 

314,649

 

 

 

343,724

 

Cash, cash equivalents, restricted cash, and cash included in settlement assets at end of the period

 

$

507,979

 

 

$

326,282

 

Cash and cash equivalents

 

 

474,738

 

 

 

275,359

 

Restricted cash

 

 

24,998

 

 

 

25,663

 

Cash and cash equivalents included in settlement assets

 

 

8,243

 

 

 

25,260

 

Cash, cash equivalents, restricted cash and cash included in settlement assets

 

$

507,979

 

 

$

326,282

 

 

EVERTEC, Inc.

Schedule 4: Unaudited Segment Information

 

 

Three months ended September 30, 2025

(In thousands)

Payment

Services –

Puerto Rico & Caribbean

 

Latin America Payments and Solutions

 

Merchant

Acquiring, net

 

Business

Solutions

 

Total Reportable Segments

 

Corporate and Other(1)

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

55,244

 

$

90,378

 

$

46,753

 

$

61,679

 

$

254,054

 

$

(25,467

)

 

$

228,587

Adjusted EBITDA

 

29,874

 

 

24,426

 

 

18,611

 

 

25,100

 

 

98,011

 

 

(5,400

)

 

 

92,611

(1)

Corporate and Other consists of corporate overhead, certain leveraged activities, other non-operating expenses and intersegment eliminations. Intersegment revenue eliminations predominantly reflect the $14.9 million processing fee from Payments Services – Puerto Rico & Caribbean to Merchant Acquiring, intercompany software developments and transaction-processing of $7.0 million from Latin America Payments and Solutions to both Payment Services- Puerto Rico & Caribbean and Business Solutions, and transaction-processing and monitoring fees of $3.6 million from Payment Services – Puerto Rico & Caribbean to Latin America Payments and Solutions.

 
 

 

Three months ended September 30, 2024

(In thousands)

Payment

Services –

Puerto Rico & Caribbean

 

Latin America Payments and Solutions

 

Merchant

Acquiring, net

 

Business

Solutions

 

Total Reportable Segments

 

Corporate and Other(1)

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

52,755

 

$

76,029

 

$

45,437

 

$

61,103

 

$

235,324

 

$

(23,529

)

 

$

211,795

Adjusted EBITDA

 

28,352

 

 

20,740

 

 

18,227

 

 

25,504

 

 

92,823

 

 

(5,434

)

 

 

87,389

(1)

Corporate and Other consists of corporate overhead, certain leveraged activities, other non-operating expenses and intersegment eliminations. Intersegment revenue eliminations predominantly reflect the $14.4 million processing fee from Payments Services – Puerto Rico & Caribbean to Merchant Acquiring, intercompany software developments and transaction-processing of $5.5 million from Latin America Payments and Solutions to both Payment Services – Puerto Rico & Caribbean and Business Solutions, and transaction-processing and monitoring fees of $3.7 million from Payment Services – Puerto Rico & Caribbean to Latin America Payments and Solutions.

 
 

 

Nine months ended September 30, 2025

(In thousands)

Payment

Services –

Puerto Rico & Caribbean

 

Latin America Payments and Solutions

 

Merchant

Acquiring, net

 

Business

Solutions

 

Total Reportable Segments

 

Corporate and Other(1)

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

166,822

 

$

260,208

 

$

141,694

 

$

191,762

 

$

760,486

 

$

(73,500

)

 

$

686,986

Adjusted EBITDA

 

94,340

 

 

72,671

 

 

58,972

 

 

73,343

 

 

299,326

 

 

(24,711

)

 

 

274,615

(1)

Corporate and Other consists of corporate overhead, certain leveraged activities, other non-operating expenses and intersegment eliminations. Intersegment revenue eliminations predominantly reflect the $44.1 million processing fee from Payments Services – Puerto Rico & Caribbean to Merchant Acquiring, intercompany software developments and transaction-processing of $18.8 million from Latin America Payments and Solutions to both Payment Services – Puerto Rico & Caribbean and Business Solutions, and transaction-processing and monitoring fees of $10.6 million from Payment Services – Puerto Rico & Caribbean to Latin America Payments and Solutions.

 
 

 

Nine months ended September 30, 2024

(In thousands)

Payment

Services –

Puerto Rico & Caribbean

 

Latin America Payments and Solutions

 

Merchant

Acquiring, net

 

Business

Solutions

 

Total Reportable Segments

 

Corporate and Other(1)

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

159,985

 

$

224,914

 

$

133,855

 

$

181,567

 

$

700,321

 

$

(71,230

)

 

$

629,091

Adjusted EBITDA

 

90,062

 

 

54,537

 

 

52,695

 

 

78,312

 

 

275,606

 

 

(23,988

)

 

 

251,618

(1)

Corporate and Other consists of corporate overhead, certain leveraged activities, other non-operating expenses and intersegment eliminations. Intersegment revenue eliminations predominantly reflect the $43.2 million processing fee from Payments Services – Puerto Rico & Caribbean to Merchant Acquiring, intercompany software developments and transaction-processing of $14.7 million from Latin America Payments and Solutions to both Payment Services – Puerto Rico & Caribbean and Business Solutions, and transaction-processing and monitoring fees of $13.4 million from Payment Services – Puerto Rico & Caribbean to Latin America Payments and Solutions.

 

EVERTEC, Inc.

Schedule 5: Reconciliation of GAAP to Non-GAAP Operating Results

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

(Dollar amounts in thousands, except share data)

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Revenue

 

$

228,587

 

 

$

211,795

 

 

$

686,986

 

 

$

629,091

 

Currency Adjustment – Constant (1)

 

 

(654

)

 

 

 

 

$

9,308

 

 

 

 

Constant Currency Revenue

 

$

227,933

 

 

$

211,795

 

 

$

696,294

 

 

$

629,091

 

 

 

 

 

 

 

 

 

 

Net income

 

$

33,460

 

 

$

25,202

 

 

$

107,524

 

 

$

74,112

 

Income tax (benefit) expense

 

 

(31

)

 

 

1,707

 

 

 

8,175

 

 

 

3,100

 

Interest expense, net

 

 

12,518

 

 

 

15,008

 

 

 

39,895

 

 

 

47,078

 

Depreciation and amortization

 

 

28,435

 

 

 

33,660

 

 

 

85,217

 

 

 

101,051

 

EBITDA

 

 

74,382

 

 

 

75,577

 

 

 

240,811

 

 

 

225,341

 

Equity loss (income) (2)

 

 

2,129

 

 

 

1,929

 

 

 

(815

)

 

 

(238

)

Compensation and benefits (3)

 

 

8,133

 

 

 

7,595

 

 

 

27,727

 

 

 

23,186

 

Transaction, refinancing and other fees (4)

 

 

7,907

 

 

 

1,176

 

 

 

7,347

 

 

 

165

 

Loss (Gain) on foreign currency remeasurement (5)

 

 

60

 

 

 

1,112

 

 

 

(455

)

 

 

3,164

 

Adjusted EBITDA

 

 

92,611

 

 

 

87,389

 

 

 

274,615

 

 

 

251,618

 

Operating depreciation and amortization (6)

 

 

(16,892

)

 

 

(16,293

)

 

 

(50,416

)

 

 

(45,732

)

Cash interest expense, net (7)

 

 

(12,039

)

 

 

(13,908

)

 

 

(38,034

)

 

 

(43,749

)

Income tax expense (8)

 

 

(3,287

)

 

 

(1,234

)

 

 

(10,930

)

 

 

(3,298

)

Non-controlling interest (9)

 

 

(609

)

 

 

(535

)

 

 

(1,526

)

 

 

(1,601

)

Adjusted Net Income

 

$

59,784

 

 

$

55,419

 

 

$

173,709

 

 

$

157,238

 

Net income per common share (GAAP):

 

 

 

 

 

 

 

 

Diluted

 

$

0.51

 

 

$

0.38

 

 

$

1.64

 

 

$

1.11

 

Adjusted earnings per common share (Non-GAAP):

 

 

 

 

 

 

 

 

Diluted

 

$

0.92

 

 

$

0.86

 

 

$

2.69

 

 

$

2.41

 

Shares used in computing adjusted earnings per common share:

 

 

 

 

 

 

 

 

Diluted

 

 

64,766,300

 

 

 

64,719,129

 

 

 

64,692,541

 

 

 

65,316,948

 

__________________
(1)

Constant currency adjustment is calculated by applying prior-year period foreign currency exchange rates to current-period results.

(2)

Represents the elimination of non-cash equity earnings from equity investments, net of dividends received.

(3)

Primarily represents share-based compensation and severance payments.

(4)

Primarily represents fees and expenses associated with corporate transactions as defined in the Credit Agreement, multi-year non-recurring gains recognized in connection with the sale of tax credits and other non-recurring expenses.

(5)

Represents non-cash unrealized losses and (gains) on foreign currency remeasurement for assets and liabilities denominated in non-functional currencies.

(6)

Represents operating depreciation and amortization expense, which excludes amounts generated as a result of merger and acquisition activity.

(7)

Represents interest expense, less interest income, as they appear on the unaudited condensed consolidated statements of income and comprehensive income (loss), adjusted to exclude non-cash amortization of the debt issue costs and premiums, and accretion of discount.

(8)

Represents income tax expense calculated on adjusted pre-tax income using the applicable GAAP tax rate, adjusted for certain discrete items.

(9)

Represents the non-controlling equity interests, net of amortization for intangibles created as part of the purchase.

 

EVERTEC, Inc.

Schedule 6: Outlook Summary and Reconciliation to Non-GAAP Adjusted Earnings per Share

 

 

 

Outlook 2025

 

 

2024

 

(Dollar amounts in millions, except per share data)

 

Low

 

 

 

High

 

 

Revenues (GAAP)

 

$

921

 

 

to

 

$

927

 

 

$

845

 

Currency adjustment – constant (1)

 

 

7

 

 

 

 

 

7

 

 

 

Constant currency revenues (Non-GAAP)

 

 

928

 

 

 

 

 

934

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per Share (EPS) (GAAP)

 

$

2.27

 

 

to

 

$

2.32

 

 

$

1.73

 

Per share adjustment to reconcile GAAP EPS to Non-GAAP Adjusted EPS:

 

 

 

 

 

 

 

 

Share-based comp, non-cash equity earnings and other (2)

 

 

0.66

 

 

 

 

 

0.66

 

 

 

0.48

 

Merger and acquisition related depreciation and amortization (3)

 

 

0.72

 

 

 

 

 

0.72

 

 

 

1.02

 

Non-cash interest expense (4)

 

 

0.04

 

 

 

 

 

0.04

 

 

 

0.07

 

Tax effect of non-gaap adjustments (5)

 

 

(0.10

)

 

 

 

 

(0.09

)

 

 

(0.02

)

Non-controlling interest (6)

 

 

(0.03

)

 

 

 

 

(0.03

)

 

 

 

Total adjustments

 

 

1.29

 

 

 

 

 

1.30

 

 

 

1.55

 

Adjusted EPS (Non-GAAP)

 

$

3.56

 

 

to

 

$

3.62

 

 

$

3.28

 

Currency adjustment – constant (1)

 

 

0.03

 

 

 

 

 

0.04

 

 

 

Constant Currency Adjusted EPS (Non-GAAP)

 

$

3.59

 

 

 

 

$

3.66

 

 

 

Shares used in computing adjusted earnings per common share

 

 

 

 

 

 

64.7

 

 

 

65.1

 

________________
(1)

Constant currency adjustment is calculated by applying prior-year period foreign currency exchange rates to current-period results.

(2)

Represents share-based compensation, the elimination of non-cash equity earnings from equity investments, severance and other adjustments to reconcile GAAP EPS to Non-GAAP EPS.

(3)

Represents depreciation and amortization expenses amounts generated as a result of M&A activity.

(4)

Represents non-cash amortization of the debt issue costs and premiums and accretion of discount.

(5)

Represents income tax expense on non-GAAP adjustments using the applicable GAAP tax rate (anticipated at approximately 6% to 7%).

(6)

Represents the non-controlling equity interests, net of amortization for intangibles created as part of the purchase.

 

Investor Contact

Loyda Montes Santiago

(787) 773-5442

[email protected]

KEYWORDS: Latin America Caribbean Puerto Rico

INDUSTRY KEYWORDS: Professional Services Payments Technology Finance Software Fintech

MEDIA:

Logo
Logo

Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update

  • Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL)

    • ALPHA3 Positions Company at the Forefront of MRD-guided, Earlier-Line Oncology Treatment
    • Additional Sites in Australia and South Korea Expected to Open in early 2026
    • Scheduled Futility Analysis, Focused on MRD Conversion Between Study Arms, on Track for 1H 2026
  • Phase 1 RESOLUTION Trial with ALLO-329 in Autoimmune Disease (AID)

    • ALLO-329, a Dual CD19/CD70 CAR, Harnesses the Dagger® Technology to Reduce or Eliminate Lymphodepletion
    • RESOLUTION Basket Trial in Rheumatology Enrolling with Proof-of-Concept Data Planned for 1H 2026
  • Phase 1 TRAVERSE Trial with ALLO-316 in Renal Cell Carcinoma (RCC)

    • ALLO-316 Achieves Durable Responses in RCC Representing a Potential Breakthrough for CAR T in Solid Tumors; Plans Ongoing to Determine the Next Phase of the Program
  • Ended Q3 2025 with $277.1 Million in Cash, Cash Equivalents and Investments; Cash Runway Continued to be Projected Into 2H 2027
  • Conference Call and Webcast Scheduled for Today at 2:00 PM PT/5:00 PM ET

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today provided corporate updates and reported financial results for the quarter ended September 30, 2025. The Company continues to advance a portfolio that seeks to redefine access to cell therapy, bringing the power of CAR T earlier in disease, more reliably, and across a broader range of treatment settings.

“With our unique allogeneic approach to CAR T, the field has the ability to shift from highly personalized, patient-specific therapies to a new era of readily available, off-the-shelf treatments that can reach more patients earlier in their disease and wherever they receive care,” said David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder of Allogene. “Having treated hundreds of patients, we’ve gained valuable insight into how ex vivo manufacturing enables more precise definition and control of our cell products before they reach patients, enhancing consistency, safety, and quality. This transformation is evident and goes far beyond incremental progress, it begins to establish a scalable allogeneic CAR T paradigm built to reach more patients, expand into broader care settings, and unlock the full potential of cell therapy.”

Cema-Cel: Pivotal Phase 2 ALPHA3 1L Consolidation Trial in LBCL

The pivotal Phase 2 ALPHA3 trial with cema-cel is pioneering the use of allogeneic CAR T therapy in earlier-line treatment of LBCL, an approach that could expand access for patients before disease progression and simplify delivery across community and academic centers. By leveraging minimal residual disease (MRD) as a guide for treatment intervention, a rapidly emerging focus across oncology, the ALPHA3 trial aims to position Allogene at the forefront of a transformative shift toward earlier, more precise, treatment. More than 50 clinical sites are active across the United States and Canada, spanning both community cancer centers and leading academic institutions. Additional sites in Australia and South Korea are progressing toward activation and are expected to open in early 2026.

The next milestone will be the futility analysis comparing MRD conversion between the two arms comparing cema-cel after standard fludarabine and cyclophosphamide (FC) lymphodepletion versus observation, expected in the first half of 2026. At that time, the Company plans to share MRD conversion rates from the randomized portion of the study.

ALLO-329: CD19/CD70 Dual CAR with Dagger

®

Technology in AID

The Phase 1 RESOLUTION trial with ALLO-329, a dual CD19/CD70 CAR incorporating Dagger® technology, is enrolling in a basket trial across multiple autoimmune conditions, including systemic lupus erythematosus (with or without lupus nephritis), idiopathic inflammatory myopathies, and systemic sclerosis. In this dose-escalation study, two treatment regimens are being explored: one with reduced intensity cyclophosphamide-only lymphodepletion, and the other with no lymphodepletion at all, a potential breakthrough for improving tolerability and enabling treatment in a broader patient population.

With its built-in lymphodepletion coming from the Dagger® technology as well as its ability to target both B cells and activated T cells, key drivers of autoimmune pathology, ALLO-329 represents one of the first to investigate how allogeneic CAR T could be uniquely suited to treat autoimmune disease at scale, with reduced or without lymphodepletion to facilitate a broader CAR T adoption in autoimmune indications. The first clinical update, expected in 1H 2026, will include biomarker data and clinical proof-of-concept data.

ALLO-316: TRAVERSE Trial in RCC

ALLO-316 remains the only allogeneic CAR T therapy to show clinically significant response rates and meaningful durability of response in a metastatic solid tumor. The TRAVERSE trial in renal cell carcinoma has completed enrollment in its Phase 1b cohort, evaluating ALLO-316 in heavily pretreated patients. Updated data presented at the 2025 ASCO Annual Meeting demonstrated early signs of efficacy and tolerability.

2025 Third Quarter Financial Results

  • Research and development expenses were $31.2 million for the third quarter of 2025, which includes $2.8 million of non-cash stock-based compensation expense.
  • General and administrative expenses were $13.7 million for the third quarter of 2025, which includes $5.9 million of non-cash stock-based compensation expense.
  • Net loss for the third quarter of 2025 was $41.4 million, or $0.19 per share, including non-cash stock-based compensation expense of $8.7 million.
  • The Company had $277.1 million in cash, cash equivalents, and investments as of September 30, 2025.

The Company continues to expect its cash runway to extend into the second half of 2027. Guidance for 2025 is an expected decrease in cash, cash equivalents, and investments of approximately $150 million. GAAP Operating Expenses are expected to be approximately $230 million, including estimated non-cash stock-based compensation expense of approximately $45 million. These estimates exclude any impact from potential business development activities.

Conference Call and Webcast Details

Allogene will host a live conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss financial results and provide a business update. If you would like the option to ask a question on the conference call, please use this link to register. Upon registering for the conference call, you will receive a personal PIN to access the call, which will identify you as the participant and allow you the option to ask a question. The listen-only webcast will be made available on the Company’s website at www.allogene.com under the Investors tab in the News and Events section. Following the live audio webcast, a replay will be available on the Company’s website for approximately 30 days.

About Allogene Therapeutics

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. For more information, please visit www.allogene.com, and follow Allogene Therapeutics on X and LinkedIn.

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This press release may, in some cases, use terms such as “expect,” “project,” “plan,” “scheduled,” “on track,” “aim,” “will,” “may,” “could,” “guidance,” “estimate,” “can,” and “potential,” and similar expressions that convey uncertainty of future events or outcomes to identify these forward-looking statements. Forward-looking statements include statements regarding intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things: market trends, including any shift toward certain therapies; the markets for our product candidates, including redefining access to cell therapy, expanding CAR T into new therapeutic settings, and our ability to reach more patients, expand into broader care settings, or simplify CAR T delivery; our ability to control ex vivo manufacturing and consistently produce product meeting safety and quality standards; our position at the forefront of a transformative shift toward earlier, more precise treatment; the design, timing, and potential regulatory implications of the ALPHA3 trial of cema-cel (including futility analysis, MRD conversion readouts, and anticipated site activations); the RESOLUTION trial of ALLO-329 (including biomarker and proof-of-concept timing and the potential to reduce or eliminate lymphodepletion); the TRAVERSE program for ALLO-316; the potential benefits and scalability of our allogeneic CAR T and Dagger® technologies; and our financial outlook, including cash runway into the second half of 2027 and 2025 operating expense and cash usage guidance. Various factors may cause material differences between Allogene’s expectations and actual results, including risks and uncertainties related to: clinical development risks, including our novel allogeneic CAR T approach and the unproven first-line consolidation setting in LBCL, the possibility that early or Phase 1 data may not predict later outcomes, trial delays or enrollment challenges, and adverse events (including those previously observed in certain ALPHA3 arms); regulatory risks, including potential FDA or foreign authority disagreement with plans or interpretations, requests for additional data or trials, and possible requirements related to MRD assays; manufacturing and CMC risks, including challenges in consistent, scalable manufacturing and technology implementation that could affect timelines, outcomes, or availability; reliance on third parties, including licensors and collaborators (e.g., Cellectis, Servier, and Foresight Diagnostics); and financial risks relating to continued operating losses, the need for additional financing, and the possibility of not meeting financial guidance. These and other risks are discussed in greater detail in Allogene’s filings with the Securities and Exchange Commission (SEC), including, without limitation, under the “Risk Factors” heading in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, being filed with the SEC today. Any forward-looking statements made in this press release speak only as of the date of this press release. Allogene assumes no obligation to update forward-looking statements, whether as a result of new information, future events, or otherwise, after the date of this press release.

AlloCAR T and Dagger® are trademarks of Allogene Therapeutics, Inc.

Allogene’s investigational AlloCAR T oncology products utilize Cellectis technologies. The anti-CD19 oncology products are developed based on an exclusive license granted by Cellectis to Servier. Servier, which has an exclusive license to the anti-CD19 AlloCAR T investigational products from Cellectis, has granted Allogene exclusive rights to these products in the U.S., all EU Member States and the United Kingdom. The anti-CD70 AlloCAR T program is licensed exclusively from Cellectis by Allogene and Allogene holds global development and commercial rights to this AlloCAR T program. ALLO-329 (CD19/CD70) in autoimmune disease uses CRISPR gene-editing technology.

ALLOGENE THERAPEUTICS, INC.

SELECTED FINANCIAL DATA

(unaudited; in thousands, except share and per share data)

STATEMENTS OF OPERATIONS
  Three Months Ended September 30,
    2025       2024  
Operating expenses:      
Research and development $ 31,164     $ 44,713  
General and administrative   13,737       16,333  
Impairment of long-lived assets         10,728  
Total operating expenses   44,901       71,774  
Loss from operations   (44,901 )     (71,774 )
Other income (expense), net:      
Interest and other income, net   3,926       6,705  
Interest expense   (344 )     (100 )
Other income (expenses), net   (81 )     (1,124 )
Total other income (expense), net   3,501       5,481  
Net loss $ (41,400 )   $ (66,293 )
Net loss per share, basic and diluted $ (0.19 )   $ (0.32 )
Weighted-average number of shares used in computing net loss per share, basic and diluted   222,038,680       209,188,551  
 

SELECTED BALANCE SHEET DATA
  As of September 30, 2025   As of December 31, 2024
Cash, cash equivalents and investments $ 277,138   $ 373,149
Total assets   439,771     548,710
Total liabilities   124,442     126,531
Total stockholders’ equity   315,329     422,179
 

Allogene Media/Investor Contact:

Christine Cassiano
EVP, Chief Corporate Affairs & Brand Strategy Officer
[email protected]



Joby to Sell up to $250 Million of Aircraft and Services in Kazakhstan

Joby to Sell up to $250 Million of Aircraft and Services in Kazakhstan

  • Agreement with Alatau Advance Air Group covers sale of aircraft and services to establish Kazakhstan’s first air taxi service
  • Republic of Kazakhstan’s Ministry of AI and Digital Development commits to delivering regulatory and infrastructure support required to establish air taxi services
  • Deal includes collaboration on access to critical materials required for manufacturing Joby’s aircraft
  • Agreement positions Kazakhstan as a regional hub for advanced air mobility

ASTANA, Republic of Kazakhstan & SANTA CRUZ, Calif.–(BUSINESS WIRE)–
Joby Aviation, Inc. (NYSE:JOBY), a company developing electric air taxis for commercial passenger service, today announced it has signed a letter of intent to sell electric vertical takeoff and landing (eVTOL) aircraft and services valued at up to $250 million to Alatau Advance Air Group (“AAAG”), a company dedicated to introducing air taxis to Kazakhstan. The agreement, which includes pre-delivery payments, is being supported by a parallel memorandum of understanding between Joby and the Ministry of Artificial Intelligence and Digital Development of the Republic of Kazakhstan. The Ministry has committed to embracing the development of Advanced Air Mobility in Kazakhstan, including the creation of the regulatory environment and infrastructure required for the successful implementation of air taxis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106504427/en/

AAAG is at the forefront of the development of Alatau City, a 340 square mile city development project that is set to become a Central Asian international hub and an early launch market for air taxis in the region. The parties will also collaborate on sourcing critical materials, including titanium and rare earth metals, from Kazakhstan for the production of Joby’s aircraft.

“Kazakhstan is taking a step into the future of innovative transportation. The purchase of electric eVTOL aircraft will mark an important milestone in the development of smart cities and the adoption of cutting-edge technologies. This initiative will contribute to the growth of Alatau City as a unique hub of advanced technologies of the future,” said Zhaslan Madiyev, Deputy Prime Minister and Minister of Artificial Intelligence and Digital Development of the Republic of Kazakhstan.

“We are deploying our proven market-entry playbook in Kazakhstan by partnering with both the government and a strategic regional operator to accelerate our path to commercial operations,” said JoeBen Bevirt, CEO and founder of Joby. “Kazakhstan is positioning itself to become a key hub for advanced air mobility and the expansion of Joby’s service into the Central Asia region.”

“We envision bringing urban air mobility to life in Kazakhstan, beginning with the newly-developed smart city of Alatau and the metropolitan hub of Almaty. Our ambition is to become the region’s first launch customer for eVTOL aircraft, establish a comprehensive testbed and ground infrastructure, and support the Government of Kazakhstan in creating a robust regulatory environment for safe and reliable operations,” said Sergey Khegay, CEO of Alatau Advance Air Group Ltd. “We welcome the opportunity to collaborate with one of the United States’ leading manufacturers of next-generation electric aircraft.”

About Joby

Joby Aviation, Inc. (NYSE:JOBY) is a California-based transportation company developing an all-electric, vertical take-off and landing air taxi. Joby intends to both operate its fast, quiet, and convenient air taxi service in cities around the world and sell its aircraft to other operators and partners. To learn more, visit www.jobyaviation.com.

About Ministry of Artificial Intelligence and Digital Development of the Republic of Kazakhstan

The Ministry is a government body responsible for the implementation of artificial intelligence technologies across various sectors of the economy, as well as for providing leadership and intersectoral coordination in the fields of electronic industry and scientific and technological development of the country.

About AAAG

Alatau Advance Air Group Ltd. is a private company registered at Astana Financial Center in Kazakhstan dedicated to bringing Advanced Air Mobility solutions to Kazakhstan, with a focus on Alatau and Almaty cities.

Forward-Looking Statements ​​

This release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the development and performance of our aircraft, the growth of our manufacturing capabilities, our regulatory outlook, progress and timing; our plans to sell aircraft valued at up to $250 million to AAAG and other related activities in Kazakhstan; our business plan, objectives, goals and market opportunity; plans for, and potential benefits of, our strategic partnerships; and our current expectations relating to our business, financial condition, results of operations, prospects, capital needs and growth of our operations, including the expected benefits of our vertically-integrated business model. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate”, “estimate”, “expect”, “project”, “plan”, “intend”, “believe”, “may”, “will”, “should”, “can have”, “likely” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. All forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including: our ability to launch our air taxi service and the growth of the urban air mobility market generally; our ability to produce aircraft that meet our performance expectations in the volumes and on the timelines that we project; complexities related to obtaining certification and operating in foreign markets; aircraft sales to AAAG will be subject to the negotiation of definitive agreements, which we may not be able to enter into on acceptable terms or at all; the competitive environment in which we operate; our future capital needs; our ability to adequately protect and enforce our intellectual property rights; our reliance on third-party suppliers and service partners; uncertainties related to our estimates of the size of the market for our service and future revenue opportunities; and other important factors discussed in the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on February 27, 2025, our Quarterly Reports on Form 10-Q filed with the SEC on May 8, 2025 and August 7, 2025, and in future filings and other reports we file with or furnish to the SEC. Any such forward-looking statements represent management’s estimates and beliefs as of the date of this release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Joby Media Contact

Charles Stewart

[email protected]

Joby Investor Contact

[email protected]

AAAG Media Contact

Ulzhan Kabdelova

[email protected]

KAZ Media Contact

[email protected]

KEYWORDS: California Kazakhstan United States North America Asia Pacific

INDUSTRY KEYWORDS: Transportation EV/Electric Vehicles Aerospace Travel Manufacturing Other Transport Automotive Alternative Energy Energy Air Transport Mining/Minerals Public Transport Natural Resources

MEDIA:

Photo
Photo
Logo
Logo

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences.

  • Jefferies Global Healthcare Conference in London, UK
    Presentation on Wednesday, November 19, 2025, at 8:00 a.m. Greenwich Mean Time
  • Piper Sandler 37th Annual Healthcare Conference in New York, NY
    Fireside chat on Wednesday, December 3, 2025, at 8:30 a.m. Eastern Time

Interested parties may access live and archived webcasts of the session on the “Investors” section of the company website at: www.adaptivebiotech.com.

About Adaptive Biotechnologies

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business segments: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

ADAPTIVE INVESTORS

Karina Calzadilla, Vice President, Investor Relations and FP&A
201-396-1687
[email protected]

ADAPTIVE MEDIA

Erica Jones, Associate Corporate Communications Director
206-279-2423
[email protected]



NerdWallet Reports Third Quarter 2025 Results

NerdWallet Reports Third Quarter 2025 Results

Revenue of $215.1 million, Up 12% Year-Over-Year

FINANCIAL HIGHLIGHTS

  • Revenue of $215.1 million
  • GAAP income from operations of $34.4 million
  • GAAP net income of $26.3 million or $0.34 income per diluted share
  • Non-GAAP operating income of $41.3 million
  • Adjusted EBITDA of $53.6 million

 

SAN FRANCISCO–(BUSINESS WIRE)–NerdWallet, Inc. (Nasdaq: NRDS), which provides trustworthy financial guidance to consumers and small and mid-sized businesses (SMBs), today reported financial results for its third quarter ended September 30, 2025.

“Our performance marketing and operational efficiency gains in the past few quarters have set us up for long-term growth and resulted in revenue of $215 million and non-GAAP operating income of $41 million in Q3,” said Tim Chen, Co-Founder and Chief Executive Office of NerdWallet. “We’re confident our trusted brand and distribution will enable us to convert our traffic into lasting consumer relationships, making it a no-brainer to shop for financial products with NerdWallet.”

THIRD QUARTER 2025 HIGHLIGHTS

  • Insurance revenue of $70.9 million increased 3% year-over-year.
  • Credit cards revenue of $34.1 million decreased 25% year-over-year, primarily due to continued headwinds in organic search traffic.
  • SMB products revenue of $23.6 million was down 15% year-over-year, primarily due to continued headwinds in organic search traffic.
  • Loans revenue of $39.6 million was up 66% year-over-year, primarily due to increases in personal loans, as well as in mortgage loans where we continue to integrate our October 2024 acquisition of Next Door Lending.
  • Emerging verticals revenue of $46.9 million was up 83% year-over-year, primarily driven by growth in banking products.
  • Underspent on brand marketing versus our target by $8 million as we reevaluated our brand strategy during the quarter. In Q4, we expect to return to more typical levels of brand spend.

SUMMARY FINANCIAL RESULTS

 

 

Quarter Ended

 

%

Change

 

Quarter Ended

 

%

Change

 

 

Sep 30,

 

Sep 30,

 

 

Jun 30,

 

(in millions, except per share amounts)

 

 

2025

 

 

2024

 

YoY

 

 

2025

 

QoQ

Revenue(1)

 

$

215.1

 

$

191.3

 

12

%

 

$

186.9

 

15

%

Insurance(2)

 

 

70.9

 

 

68.7

 

3

%

 

 

54.7

 

30

%

Credit cards(3)

 

 

34.1

 

 

45.3

 

(25

%)

 

 

34.8

 

(2

%)

SMB products(4)

 

 

23.6

 

 

27.8

 

(15

%)

 

 

25.0

 

(6

%)

Loans(5)

 

 

39.6

 

 

23.8

 

66

%

 

 

27.5

 

44

%

Emerging verticals(6)

 

 

46.9

 

 

25.7

 

83

%

 

 

44.9

 

4

%

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

$

34.4

 

$

6.6

 

420

%

 

$

10.7

 

223

%

Net income

 

$

26.3

 

$

0.1

 

NM

 

 

$

8.2

 

219

%

 

 

 

 

 

 

 

 

 

 

 

Net income per share

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.35

 

$

0.00

 

NM

 

 

$

0.11

 

218

%

Diluted

 

$

0.34

 

$

0.00

 

NM

 

 

$

0.11

 

209

%

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP financial measures(7)

 

 

 

 

 

 

 

 

 

 

Non-GAAP operating income

 

$

41.3

 

$

22.9

 

81

%

 

$

20.7

 

99

%

Adjusted EBITDA

 

$

53.6

 

$

37.3

 

44

%

 

$

33.6

 

59

%

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

120.6

 

$

71.7

 

68

%

 

$

105.3

 

15

%

_________________________

(1)

As previously announced, effective with the fourth quarter of 2024, we present Insurance (previously included in Emerging verticals) as a separate revenue product category. Comparative amounts have been reclassified to conform to the presentation for the three and nine months ended September 30, 2025.

(2)

Insurance revenue consists of revenue from consumer insurance products, including auto, life and pet insurance.

(3)

Credit cards revenue consists of revenue from consumer credit cards.

(4)

SMB products revenue includes revenue from loans, credit cards and other financial products and services intended for small and mid-sized businesses.

(5)

Loans revenue includes revenue from personal loans, mortgages, student loans and auto loans.

(6)

Emerging verticals revenue includes revenue from other product sources, including banking, investing and international.

(7)

Non-GAAP operating income (loss) and adjusted EBITDA are non-GAAP financial measures. See “Non-GAAP Financial Measures” for more information, including reconciliations to the most directly comparable financial measures calculated in accordance with GAAP.

QUARTERLY CONFERENCE CALL

A conference call to discuss NerdWallet’s third quarter 2025 financial results will be webcast live today, November 6, 2025 at 1:30 PM Pacific Time (PT). The live webcast is open to the public and will be available on NerdWallet’s investor relations website at https://investors.nerdwallet.com. Following completion of the call, a recorded replay of the webcast will be available on NerdWallet’s investor relations website.

SHAREHOLDER LETTER

A shareholder letter providing additional information and analysis can be found at NerdWallet’s investor relations website at https://investors.nerdwallet.com.

ABOUT NERDWALLET

NerdWallet (Nasdaq: NRDS) is on a mission to provide clarity for all of life’s financial decisions. As a personal finance website and app, NerdWallet provides consumers with trustworthy and knowledgeable financial information so they can make smart money moves. From finding the best credit card to buying a house, NerdWallet is there to help consumers make financial decisions with confidence. Consumers have free access to our expert content and comparison shopping marketplaces, plus a data-driven app, which helps them stay on top of their finances and save time and money, giving them the freedom to do more. NerdWallet is available for consumers in the U.S., United Kingdom and Canada.

“NerdWallet” is a trademark of NerdWallet, Inc. All rights reserved. Other names and trademarks used herein may be trademarks of their respective owners.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Unaudited

 

 

 

Three Months Ended

September 30,

 

% Change

 

Nine Months Ended

September 30,

 

% Change

(in millions, except per share amounts)

 

 

2025

 

 

 

2024

 

 

 

 

2025

 

 

 

2024

 

 

Revenue

 

$

215.1

 

 

$

191.3

 

 

12

%

 

$

611.2

 

 

$

503.8

 

 

21

%

Costs and Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

15.3

 

 

 

17.7

 

 

(13

%)

 

 

50.1

 

 

 

46.8

 

 

7

%

Research and development

 

 

15.7

 

 

 

23.0

 

 

(31

%)

 

 

50.4

 

 

 

66.4

 

 

(24

%)

Sales and marketing

 

 

135.3

 

 

 

128.1

 

 

6

%

 

 

423.0

 

 

 

342.1

 

 

24

%

General and administrative

 

 

14.4

 

 

 

15.9

 

 

(10

%)

 

 

41.9

 

 

 

47.8

 

 

(12

%)

Total costs and expenses

 

 

180.7

 

 

 

184.7

 

 

(2

%)

 

 

565.4

 

 

 

503.1

 

 

12

%

Income from Operations

 

 

34.4

 

 

 

6.6

 

 

420

%

 

 

45.8

 

 

 

0.7

 

 

NM

 

Other income, net:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

1.0

 

 

 

1.3

 

 

(23

%)

 

 

2.5

 

 

 

4.2

 

 

(41

%)

Interest expense

 

 

(0.2

)

 

 

(0.1

)

 

3

%

 

 

(0.5

)

 

 

(0.5

)

 

(11

%)

Other gains (losses), net

 

 

0.3

 

 

 

 

 

296

%

 

 

0.5

 

 

 

(0.1

)

 

NM

 

Total other income, net

 

 

1.1

 

 

 

1.2

 

 

(10

%)

 

 

2.5

 

 

 

3.6

 

 

(31

%)

Income before income taxes

 

 

35.5

 

 

 

7.8

 

 

356

%

 

 

48.3

 

 

 

4.3

 

 

NM

 

Income tax provision

 

 

9.2

 

 

 

7.7

 

 

19

%

 

 

13.6

 

 

 

12.5

 

 

8

%

Net Income (Loss)

 

$

26.3

 

 

$

0.1

 

 

NM

 

 

$

34.7

 

 

$

(8.2

)

 

NM

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) per Share Attributable to Common Stockholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.35

 

 

$

0.00

 

 

NM

 

 

$

0.46

 

 

$

(0.11

)

 

NM

 

Diluted

 

$

0.34

 

 

$

0.00

 

 

NM

 

 

$

0.45

 

 

$

(0.11

)

 

NM

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average Shares Used in Computing Net Income (Loss) per Share Attributable to Common Stockholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

75.7

 

 

 

77.4

 

 

 

 

 

74.9

 

 

 

77.5

 

 

 

Diluted

 

 

76.9

 

 

 

79.3

 

 

 

 

 

76.5

 

 

 

77.5

 

 

 

CONDENSED CONSOLIDATED BALANCE SHEETS

Unaudited

 

(in millions)

 

September 30,

2025

 

December 31,

2024

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

120.6

 

$

66.3

Accounts receivable—net

 

 

121.9

 

 

102.2

Prepaid expenses and other current assets

 

 

32.6

 

 

28.2

Total current assets

 

 

275.1

 

 

196.7

Property, equipment and software—net

 

 

32.7

 

 

43.0

Goodwill

 

 

115.7

 

 

112.4

Intangible assets—net

 

 

24.8

 

 

33.3

Deferred tax asset—noncurrent

 

 

33.8

 

 

45.6

Right-of-use assets

 

 

7.6

 

 

5.3

Other assets

 

 

3.1

 

 

1.3

Total Assets

 

$

492.8

 

$

437.6

Liabilities and Stockholders’ Equity

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

13.6

 

$

8.9

Accrued expenses and other current liabilities

 

 

60.8

 

 

51.2

Total current liabilities

 

 

74.4

 

 

60.1

Other liabilities—noncurrent

 

 

16.0

 

 

13.3

Total liabilities

 

 

90.4

 

 

73.4

Commitments and contingencies

 

 

 

 

Stockholders’ equity

 

 

402.4

 

 

364.2

Total Liabilities and Stockholders’ Equity

 

$

492.8

 

$

437.6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Unaudited

 

 

 

Nine Months Ended

September 30,

(in millions)

 

 

2025

 

 

 

2024

 

Operating Activities:

 

 

 

 

Net income (loss)

 

$

34.7

 

 

$

(8.2

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

 

36.9

 

 

 

37.0

 

Stock-based compensation

 

 

21.6

 

 

 

29.2

 

Deferred taxes

 

 

11.5

 

 

 

(0.2

)

Non-cash lease costs

 

 

1.8

 

 

 

1.7

 

Other losses, net

 

 

1.6

 

 

 

0.3

 

Changes in operating assets and liabilities:

 

 

 

 

Accounts receivable

 

 

(20.6

)

 

 

(27.3

)

Prepaid expenses and other assets

 

 

(0.7

)

 

 

3.5

 

Mortgage loans held for sale

 

 

(3.6

)

 

 

 

Accounts payable

 

 

4.8

 

 

 

10.3

 

Accrued expenses and other current liabilities

 

 

6.4

 

 

 

16.8

 

Operating lease liabilities

 

 

(2.1

)

 

 

(2.5

)

Other liabilities

 

 

0.4

 

 

 

1.3

 

Net cash provided by operating activities

 

 

92.7

 

 

 

61.9

 

Investing Activities:

 

 

 

 

Purchase of investment

 

 

(2.0

)

 

 

(8.1

)

Capitalized software development costs

 

 

(12.4

)

 

 

(15.9

)

Purchase of property and equipment

 

 

(1.0

)

 

 

(0.4

)

Business combination

 

 

(5.0

)

 

 

 

Net cash used in investing activities

 

 

(20.4

)

 

 

(24.4

)

Financing Activities:

 

 

 

 

Net borrowing on warehouse line of credit

 

 

3.3

 

 

 

 

Proceeds from exercise of stock options

 

 

0.7

 

 

 

5.2

 

Tax payments related to net-share settlements on restricted stock units

 

 

(3.2

)

 

 

(1.7

)

Issuance of Class A common stock under Employee Stock Purchase Plan

 

 

1.0

 

 

 

 

Repurchase of Class A common stock

 

 

(19.5

)

 

 

(69.8

)

Net cash used in financing activities

 

 

(17.7

)

 

 

(66.3

)

Effect of exchange rate changes on cash and cash equivalents

 

 

(0.3

)

 

 

0.1

 

Net increase (decrease) in cash and cash equivalents

 

 

54.3

 

 

 

(28.7

)

Cash and Cash Equivalents:

 

 

 

 

Beginning of period

 

 

66.3

 

 

 

100.4

 

End of period

 

$

120.6

 

 

$

71.7

 

NON-GAAP FINANCIAL MEASURES

We use non-GAAP operating income (loss), adjusted EBITDA and adjusted free cash flow in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our Board of Directors concerning our financial performance.

Non-GAAP operating income (loss): We define non-GAAP operating income (loss) as income (loss) from operations adjusted to exclude depreciation and amortization, and further exclude (1) impairment of right-of-use asset, (2) losses (gains) on disposals of assets, (3) change in fair value of contingent consideration related to earnouts, (4) deferred compensation related to earnouts, (5) acquisition-related costs, and (6) restructuring charges. We also reduce income from operations, or increase loss from operations, for capitalized internally developed software costs.

Adjusted EBITDA: We define adjusted EBITDA as net income (loss) from continuing operations adjusted to exclude depreciation and amortization, interest income (expense), net, other gains (losses), net, and provision (benefit) for income taxes, and further exclude (1) impairment of right-of-use asset, (2) losses (gains) on disposals of assets, (3) change in fair value of contingent consideration related to earnouts, (4) deferred compensation related to earnouts, (5) stock-based compensation, (6) acquisition-related costs, and (7) restructuring charges.

The above items are excluded from our non-GAAP operating income (loss) and adjusted EBITDA measures because these items are non-cash in nature, or because the amounts are not driven by core operating results and renders comparisons with prior periods less meaningful. We deduct capitalized internally developed software costs in our non-GAAP operating income (loss) measure to reflect the cash impact of personnel costs incurred within the time period.

We believe that non-GAAP operating income (loss) and adjusted EBITDA provide useful information to investors and others in understanding and evaluating our operating results and in comparing operating results across periods. Moreover, non-GAAP operating income (loss) and adjusted EBITDA are key measurements used by our management internally to make operating decisions, including those related to analyzing operating expenses, evaluating performance, and performing strategic planning and annual budgeting. However, the use of these non-GAAP measures have certain limitations because they do not reflect all items of income and expense that affect our operations. Non-GAAP operating income (loss) and adjusted EBITDA have limitations as financial measures, should be considered as supplemental in nature, and are not meant as substitutes for the related financial information prepared in accordance with GAAP. These limitations include the following:

  • Non-GAAP operating income (loss) and adjusted EBITDA exclude certain recurring, non-cash charges, such as amortization of software, depreciation of property and equipment, amortization of intangible assets, impairment of right-of-use asset, and (losses) gains on disposals of assets. Although these are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and non-GAAP operating income (loss) and adjusted EBITDA do not reflect all cash requirements for such replacements or for new capital expenditure requirements;
  • Non-GAAP operating income (loss) and adjusted EBITDA exclude acquisition-related costs, including acquisition-related retention compensation under compensatory retention agreements with certain key employees, acquisition-related transaction expenses, contingent consideration fair value adjustments related to earnouts, and deferred compensation related to earnouts;
  • Non-GAAP operating income (loss) and adjusted EBITDA exclude restructuring charges primarily consisting of severance payments, stock-based compensation, employee benefits, and related expenses for impacted employees, as well as contract termination costs, associated with our Restructuring Plan;
  • Adjusted EBITDA excludes stock-based compensation, including for acquisition-related inducement awards, which has been, and will continue to be for the foreseeable future, a significant recurring expense in our business and an important part of our compensation strategy; and
  • Adjusted EBITDA does not reflect interest income (expense) and other gains (losses), net, which include unrealized and realized gains and losses on foreign currency exchange, as well as certain nonrecurring gains (losses).

Adjusted free cash flow: We previously defined free cash flow as net cash provided by operating activities less capitalized software development costs and purchases of property and equipment. Effective with the first quarter of 2025, we further define our adjusted free cash flow to be free cash flow adjusted for any net borrowing or repayment on our warehouse line of credit which is used to fund mortgage loans originated for sale, as any increase or decrease in our mortgage loans held for sale is substantially offset by a corresponding borrowing or repayment on our warehouse line of credit. Adjusted free cash flow is a key measurement used by our management internally to evaluate our business performance and overall liquidity. We believe that adjusted free cash flow provides useful information for investors and others for determining the amount of cash available for investment in our business, strategic opportunities, repurchasing stock, strengthening our financial position and other purposes, as well as evaluating our historical and prospective liquidity. A limitation of the utility of adjusted free cash flow as a measure of financial performance and liquidity is that adjusted free cash flow does not represent the total increase or decrease in our cash balance for the period.

In addition, non-GAAP operating income (loss), adjusted EBITDA and adjusted free cash flow as we define them may not be comparable to similarly titled measures used by other companies. Because of these limitations, you should consider non-GAAP operating income (loss), adjusted EBITDA and adjusted free cash flow alongside other financial performance measures, including income (loss) from operations, net income (loss), cash flows from operating activities and our other GAAP results.

We compensate for these limitations by reconciling non-GAAP operating income (loss) to income (loss) from operations, adjusted EBITDA to net income (loss) and adjusted free cash flow to net cash provided by operating activities, the most directly comparable GAAP financial measures, as follows:

 

 

Three Months Ended

September 30,

 

% Change

 

Nine Months Ended

September 30,

 

% Change

(in millions)

 

 

2025

 

 

 

2024

 

 

 

 

2025

 

 

 

2024

 

 

Income from Operations

 

$

34.4

 

 

$

6.6

 

 

420

%

 

$

45.8

 

 

$

0.7

 

 

NM

 

Depreciation and amortization

 

 

11.6

 

 

 

12.9

 

 

(10

%)

 

 

36.9

 

 

 

37.0

 

 

0

%

Acquisition-related retention

 

 

 

 

 

0.8

 

 

(100

%)

 

 

1.6

 

 

 

3.3

 

 

(50

%)

Acquisition-related expenses

 

 

0.9

 

 

 

0.5

 

 

82

%

 

 

1.7

 

 

 

0.6

 

 

197

%

Loss on disposal of assets

 

 

 

 

 

 

 

NM

 

 

 

0.3

 

 

 

 

 

NM

 

Restructuring

 

 

 

 

 

7.8

 

 

(100

%)

 

 

0.4

 

 

 

7.8

 

 

(95

%)

Capitalized internally developed software costs

 

 

(5.6

)

 

 

(5.7

)

 

(2

%)

 

 

(15.4

)

 

 

(18.6

)

 

(17

%)

Non-GAAP Operating Income

 

$

41.3

 

 

$

22.9

 

 

81

%

 

$

71.3

 

 

$

30.8

 

 

132

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income margin

 

 

16

%

 

 

3

%

 

 

 

 

7

%

 

 

0

%

 

 

Non-GAAP operating income margin1

 

 

19

%

 

 

12

%

 

 

 

 

12

%

 

 

6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

$

26.3

 

 

$

0.1

 

 

NM

 

 

$

34.7

 

 

$

(8.2

)

 

NM

 

Depreciation and amortization

 

 

11.6

 

 

 

12.9

 

 

(10

%)

 

 

36.9

 

 

 

37.0

 

 

0

%

Stock-based compensation

 

 

6.7

 

 

 

8.7

 

 

(23

%)

 

 

21.6

 

 

 

27.7

 

 

(22

%)

Acquisition-related retention

 

 

 

 

 

0.8

 

 

(100

%)

 

 

1.6

 

 

 

3.3

 

 

(50

%)

Acquisition-related expenses

 

 

0.9

 

 

 

0.5

 

 

82

%

 

 

1.7

 

 

 

0.6

 

 

197

%

Loss on disposal of assets

 

 

 

 

 

 

 

NM

 

 

 

0.3

 

 

 

 

 

NM

 

Restructuring

 

 

 

 

 

7.8

 

 

(100

%)

 

 

0.4

 

 

 

7.8

 

 

(95

%)

Interest income, net

 

 

(0.8

)

 

 

(1.2

)

 

(26

%)

 

 

(2.0

)

 

 

(3.7

)

 

(45

%)

Other (gains) losses, net

 

 

(0.3

)

 

 

 

 

296

%

 

 

(0.5

)

 

 

0.1

 

 

NM

 

Income tax provision

 

 

9.2

 

 

 

7.7

 

 

19

%

 

 

13.6

 

 

 

12.5

 

 

8

%

Adjusted EBITDA

 

$

53.6

 

 

$

37.3

 

 

44

%

 

$

108.3

 

 

$

77.1

 

 

41

%

Stock-based compensation

 

 

(6.7

)

 

 

(8.7

)

 

(23

%)

 

 

(21.6

)

 

 

(27.7

)

 

(22

%)

Capitalized internally developed software costs

 

 

(5.6

)

 

 

(5.7

)

 

(2

%)

 

 

(15.4

)

 

 

(18.6

)

 

(17

%)

Non-GAAP Operating Income

 

$

41.3

 

 

$

22.9

 

 

81

%

 

$

71.3

 

 

$

30.8

 

 

132

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) margin

 

 

12

%

 

 

0

%

 

 

 

 

6

%

 

 

(2

%)

 

 

Adjusted EBITDA margin2

 

 

25

%

 

 

19

%

 

 

 

 

18

%

 

 

15

%

 

________________________

(1)

Represents non-GAAP operating income (loss) as a percentage of revenue.

(2)

Represents adjusted EBITDA as a percentage of revenue.

 

 

Twelve Months Ended

(in millions)

 

Sep 30,

2025

 

Jun 30,

2025

 

Mar 31,

2025

 

Dec 31,

2024

 

Sep 30,

2024

Net cash provided by operating activities

 

$

102.6

 

 

$

83.1

 

 

$

75.8

 

 

$

71.8

 

 

$

91.5

 

Capitalized software development costs

 

 

(17.2

)

 

 

(18.0

)

 

 

(19.7

)

 

 

(20.7

)

 

 

(25.1

)

Purchase of property and equipment

 

 

(1.2

)

 

 

(1.2

)

 

 

(0.8

)

 

 

(0.6

)

 

 

(0.6

)

Net borrowing (repayment) on warehouse line of credit

 

 

1.3

 

 

 

6.7

 

 

 

2.3

 

 

 

(2.0

)

 

 

 

Adjusted free cash flow

 

$

85.5

 

 

$

70.6

 

 

$

57.6

 

 

$

48.5

 

 

$

65.8

 

FINANCIAL OUTLOOK

We are providing guidance for the fourth quarter of 2025:

  • Revenue is expected in the range of $207-$215 million, up 15% year-over-year at the midpoint
  • GAAP operating income is expected in the range of $13-$17 million
  • Non-GAAP operating income is expected in the range of $20-$24 million
  • Adjusted EBITDA is expected in the range of $33-$37 million

We are increasing our forecasted 2025 annual GAAP operating income to a range of $59-$63 million, and forecasted non-GAAP operating income to a range of $91-$95 million. We are also increasing our forecasted 2025 annual adjusted EBITDA to a range of $141-$145 million.

NerdWallet has not provided a quantitative reconciliation of forecasted GAAP net income (loss) to forecasted adjusted EBITDA within this communication because the Company is unable, without making unreasonable efforts, to calculate certain reconciling items with confidence. These items include, but are not limited to, income taxes which are directly impacted by unpredictable fluctuations in the market price of the Company’s capital stock. These items, which could materially affect the computation of forward-looking GAAP net income (loss), are inherently uncertain and depend on various factors, many of which are outside of NerdWallet’s control.

A reconciliation of forecasted GAAP operating income to forecasted non-GAAP operating income for forecasted fourth quarter 2025 and forecasted full year 2025 is as follows:

 

 

Forecasted

Fourth Quarter

 

Forecasted

Full Year

(in millions)

 

2025

 

2025

GAAP operating income

 

$13 – $17

 

$59 – $63

Estimated adjustments for:

 

 

 

 

Depreciation and amortization

 

11 – 12

 

48 – 49

Acquisition-related retention

 

 

2

Acquisition-related expenses

 

 

2

Capitalized internally developed software costs

 

(4) – (5)

 

(20) – (21)

Non-GAAP operating income

 

$20 – $24

 

$91 – $95

______________________

For more information regarding the non-GAAP financial measures discussed in this communication, please see “Non-GAAP Financial Measures” above.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements about us and our industry that involve significant risks and uncertainties. Except for statements of historical facts, all statements contained in this press release are forward-looking, including, but not limited to, the statements in the section titled “Financial Outlook.” These statements often contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “outlook,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will” or “would” or similar terms, including their negatives. These forward-looking statements include, but are not limited to, statements regarding:

  • the impact of macroeconomic developments, including inflation, interest rates, credit market conditions and general economic uncertainty, on our business, operating results, financial condition and stock price;
  • our expectations regarding future financial and operational performance, including total revenue, cost of revenue, non-GAAP operating income (loss), adjusted EBITDA, and adjusted free cash flow;
  • our ability to grow traffic, engagement, and monetization on our platform;
  • expected returns on marketing investments and brand campaigns;
  • consumer demand for products and services offered through our platform;
  • our ability to increase user registrations, improve repeat usage rates, and convert users into matches with financial services partners;
  • expansion within existing and new verticals, including new products, services, and features that are competitive, compliant with applicable regulations, and responsive to market needs;
  • changing geographic operations;
  • maintaining and expanding relationships with existing financial services partners and identifying new ones;
  • developing scalable technology and data capabilities to provide personalized guidance and enhance user engagement;
  • strengthening brand awareness, credibility, and consumer trust;
  • producing high quality, engaging consumer content and tools;
  • adapting to evolving consumer financial interests and behaviors;
  • competing effectively in existing and new markets;
  • maintaining the security, reliability, and availability of our platform;
  • protecting and enhancing our intellectual property portfolio;
  • attracting, developing, and retaining highly skilled and diverse talent;
  • complying with evolving laws, regulations, and supervisory expectations applicable to our business;
  • the adequacy of our cash, cash equivalents, and investments to meet liquidity needs;
  • managing growth, scaling infrastructure, and preserving our corporate culture;
  • identifying, executing, and successfully integrating acquisitions;
  • entering new financial services markets, and meeting associated regulatory complexities; and
  • achieving expected synergies, accretion, and other benefits from completed acquisitions.

These forward-looking statements are not guarantees of future performance and should not be relied upon as predictions of future events. They are based on our current expectations, estimates, and projections regarding future events and trends that may affect our business, financial condition and operating results. These expectations are subject to various risks, uncertainties, and assumptions, including those described in filings we make with the SEC from time to time.

Our industry is highly competitive and rapidly evolving, and new risks and uncertainties may arise that we cannot predict. As a result, actual results, events, or circumstances may differ materially from those reflected in our forward-looking statements.

Forward-looking statements in this press release speak only as of the date hereof. We undertake no obligation to update any such statements in this press release to reflect subsequent events, new information, or unexpected developments, except as required by law. These statements also do not reflect potential impacts from future acquisitions, mergers, dispositions, joint ventures, or investments.

Investor Relations:

Sara Colvin

[email protected]

Media Relations:

Maitri Jani

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Apps/Applications Technology Personal Finance Payments Finance Fintech Professional Services Digital Cash Management/Digital Assets Internet

MEDIA:

Logo
Logo